[
  {
    "id": 244256,
    "drug": {
      "current_status": "MARKETED",
      "id": 12790,
      "drug_code": 71750,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8254670,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02247500",
      "brand_name": "CLIMARA 75",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457036"
    },
    "created_date": "2024-12-02T14:30:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247500",
    "company_name": "BAYER INC",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2025-03-28T00:00:00-04:00",
    "actual_start_date": "2025-03-26T00:00:00-04:00",
    "actual_end_date": "2025-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-03-29T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLIMARA 75",
    "en_drug_common_name": "ESTRADIOL",
    "fr_drug_brand_name": "CLIMARA 75",
    "fr_drug_common_name": "Estradiol",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "75MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244275,
    "drug": {
      "current_status": "MARKETED",
      "id": 10558,
      "drug_code": 66035,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 880,
        "created_date": "2017-03-09T13:23:25-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 15192,
        "mfr_code": "",
        "name": "LABORATOIRES THEA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "12 RUE LOUIS BLERIOT",
        "province": "CEDEX 2",
        "country": "FRANCE",
        "city": "CLERMONT-FERRAND",
        "postal_code": "63017",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254007,
          "ingredient": {
            "id": 238,
            "ingredient_code": 11175,
            "en_name": "KETOTIFEN",
            "fr_name": "Kétotifène (Fumarate de kétotifène)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02242324",
      "brand_name": "ZADITOR",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115676003"
    },
    "created_date": "2024-12-02T14:55:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242324",
    "company_name": "LABORATOIRES THEA",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "anticipated_start_date": "2024-12-02T00:00:00-05:00",
    "estimated_end_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Product release to Canadian market",
    "en_drug_brand_name": "ZADITOR",
    "en_drug_common_name": "Zaditor",
    "fr_drug_brand_name": "Zaditor",
    "fr_drug_common_name": "Zaditor",
    "en_ingredients": "KETOTIFEN",
    "fr_ingredients": "Kétotifène (Fumarate de kétotifène)",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244298,
    "drug": {
      "current_status": "MARKETED",
      "id": 101491,
      "drug_code": 100048,
      "updated_date": "2021-02-08T05:57:13-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266027,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02511266",
      "brand_name": "ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241001"
    },
    "created_date": "2024-12-02T15:48:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02511266",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-30T06:00:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELETRIPTAN",
    "en_drug_common_name": "ELETRIPTAN",
    "fr_drug_brand_name": "ELETRIPTAN",
    "fr_drug_common_name": "ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "Élétriptan (Bromhydrate d'élétriptan)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244301,
    "drug": {
      "current_status": "MARKETED",
      "id": 21604,
      "drug_code": 83990,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257725,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354748",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2024-12-02T15:50:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354748",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine (Chlorhydrate de venlafaxine)",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244304,
    "drug": {
      "current_status": "MARKETED",
      "id": 102783,
      "drug_code": 101408,
      "updated_date": "2022-03-29T12:08:13-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266965,
          "ingredient": {
            "id": 2414,
            "ingredient_code": 11443,
            "en_name": "TRANDOLAPRIL",
            "fr_name": "Trandolapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02525054",
      "brand_name": "TRANDOLAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131524003"
    },
    "created_date": "2024-12-02T15:52:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02525054",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2024-12-09T00:00:00-05:00",
    "estimated_end_date": "2025-03-07T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-05T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANDOLAPRIL",
    "en_drug_common_name": "TRANDOLAPRIL",
    "fr_drug_brand_name": "TRANDOLAPRIL",
    "fr_drug_common_name": "TRANDOLAPRIL",
    "en_ingredients": "TRANDOLAPRIL",
    "fr_ingredients": "Trandolapril",
    "drug_strength": "2MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244431,
    "drug": {
      "current_status": "MARKETED",
      "id": 27538,
      "drug_code": 89782,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259952,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413140",
      "brand_name": "SANDOZ TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202002"
    },
    "created_date": "2024-12-02T19:31:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413140",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2024-12-02T00:00:00-05:00",
    "estimated_end_date": "2024-12-20T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-24T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE",
    "fr_drug_brand_name": "TOLTERODINE",
    "fr_drug_common_name": "TOLTERODINE",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "2MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244434,
    "drug": {
      "current_status": "MARKETED",
      "id": 28016,
      "drug_code": 90197,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260188,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417340",
      "brand_name": "SANDOZ CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2024-12-02T19:33:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417340",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-12-06T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-10T15:20:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "SANDOZ CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244437,
    "drug": {
      "current_status": "MARKETED",
      "id": 12504,
      "drug_code": 71198,
      "updated_date": "2025-12-03T00:30:52-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254599,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02246969",
      "brand_name": "SANDOZ ESTRADIOL DERM 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457037"
    },
    "created_date": "2024-12-02T19:34:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246969",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-12-25T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESTRADIOL DERM 100",
    "en_drug_common_name": "ESTRADIOL",
    "fr_drug_brand_name": "SANDOZ ESTRADIOL",
    "fr_drug_common_name": "ESTRADIOL",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244440,
    "drug": {
      "current_status": "MARKETED",
      "id": 17350,
      "drug_code": 78396,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256115,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298643",
      "brand_name": "SANDOZ LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663004"
    },
    "created_date": "2024-12-02T19:36:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298643",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2025-07-18T00:00:00-04:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-22T05:00:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine (Hémihydrate de lévofloxacine)",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244443,
    "drug": {
      "current_status": "MARKETED",
      "id": 28618,
      "drug_code": 90735,
      "updated_date": "2025-05-15T02:34:16-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260381,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422689",
      "brand_name": "SANDOZ LINEZOLID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501002"
    },
    "created_date": "2024-12-02T19:37:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422689",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01XX",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-10T15:21:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LINEZOLID",
    "en_drug_common_name": "LINEZOLID",
    "fr_drug_brand_name": "SANDOZ LINEZOLID",
    "fr_drug_common_name": "LINEZOLID",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244446,
    "drug": {
      "current_status": "MARKETED",
      "id": 101384,
      "drug_code": 96582,
      "updated_date": "2021-02-08T05:02:28-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8263233,
          "ingredient": {
            "id": 3698,
            "ingredient_code": 20659,
            "en_name": "SILODOSIN",
            "fr_name": "Silodosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475448",
      "brand_name": "SANDOZ SILODOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152869002"
    },
    "created_date": "2024-12-02T19:39:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475448",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2025-03-28T00:00:00-04:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-01T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ SILODOSIN",
    "en_drug_common_name": "SILODOSIN",
    "fr_drug_brand_name": "SANDOZ SILODOSIN",
    "fr_drug_common_name": "SILODOSIN",
    "en_ingredients": "SILODOSIN",
    "fr_ingredients": "Silodosine",
    "drug_strength": "8MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100HGC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244449,
    "drug": {
      "current_status": "MARKETED",
      "id": 23550,
      "drug_code": 86141,
      "updated_date": "2025-05-15T02:33:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258498,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375958",
      "brand_name": "SANDOZ TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2024-12-02T19:41:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375958",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-12-20T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-24T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "SANDOZ TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244452,
    "drug": {
      "current_status": "MARKETED",
      "id": 57524,
      "drug_code": 81112,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256903,
          "ingredient": {
            "id": 2414,
            "ingredient_code": 11443,
            "en_name": "TRANDOLAPRIL",
            "fr_name": "Trandolapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325764",
      "brand_name": "SANDOZ TRANDOLAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131524004"
    },
    "created_date": "2024-12-02T19:42:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325764",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-24T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "en_drug_common_name": "TRANDOLAPRIL",
    "fr_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "fr_drug_common_name": "TRANDOLAPRIL",
    "en_ingredients": "TRANDOLAPRIL",
    "fr_ingredients": "Trandolapril",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244475,
    "drug": {
      "current_status": "MARKETED",
      "id": 103756,
      "drug_code": 102454,
      "updated_date": "2023-03-08T06:15:14-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267918,
          "ingredient": {
            "id": 6335,
            "ingredient_code": 11079,
            "en_name": "BETA-CAROTENE",
            "fr_name": "Bétacarotène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267917,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267916,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267915,
          "ingredient": {
            "id": 1310,
            "ingredient_code": 4803,
            "en_name": "CALCIUM",
            "fr_name": "Calcium (Chlorure de calcium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267914,
          "ingredient": {
            "id": 758,
            "ingredient_code": 5000,
            "en_name": "D-PANTOTHENIC ACID",
            "fr_name": "Acide d-pantothénique (D-pantothénate de calcium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267913,
          "ingredient": {
            "id": 618,
            "ingredient_code": 7218,
            "en_name": "IODINE",
            "fr_name": "Iode"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267912,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267911,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267910,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267909,
          "ingredient": {
            "id": 506,
            "ingredient_code": 309,
            "en_name": "IRON",
            "fr_name": "Fer (Complexe fer-dextran)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267908,
          "ingredient": {
            "id": 1316,
            "ingredient_code": 6487,
            "en_name": "MAGNESIUM",
            "fr_name": "Magnésium (Chlorure de magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267907,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "13.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267906,
          "ingredient": {
            "id": 912,
            "ingredient_code": 582,
            "en_name": "COPPER",
            "fr_name": "Cuivre ((FR) COPPER OXIDE)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267905,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267904,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267903,
          "ingredient": {
            "id": 1634,
            "ingredient_code": 11169,
            "en_name": "VITAMIN B6",
            "fr_name": "Vitamine B6"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267902,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02535718",
      "brand_name": "PREGNANCY MULTIVITAMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "17",
      "ai_group_no": "1747661005"
    },
    "created_date": "2024-12-02T20:58:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02535718",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "B03AE",
    "atc_description": "IRON PREPARATIONS",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-31T20:59:31-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PREGNANCY MULTIVITAMIN",
    "en_drug_common_name": "Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use",
    "fr_drug_brand_name": "Multivitamines Maternité",
    "fr_drug_common_name": "Supplément vitaminique-minéral en comprimés pour usage prénatale et postpartum",
    "en_ingredients": "CALCIUM\r\nVITAMIN D3\r\nVITAMIN B12\r\nFOLIC ACID\r\nZINC\r\nMAGNESIUM\r\nIRON\r\nIODINE\r\nCOPPER\r\nVITAMIN E\r\nASCORBIC ACID\r\nVITAMIN B6\r\nD-PANTOTHENIC ACID\r\nNICOTINAMIDE\r\nVITAMIN B2\r\nVITAMIN B1\r\nBETA-CAROTENE",
    "fr_ingredients": "Calcium (Gluconate de calcium)\r\nVitamine D3\r\nVitamine B12 (Cyanocobalamine)\r\nAcide folique\r\nZinc (Oxyde de zinc, Sulfate de zinc)\r\nMagnésium (Chlorure de magnésium)\r\nFer (Complexe fer-dextran)\r\nIode\r\nCuivre\r\nVitamine E (Acétate de DL-alpha-tocophérol)\r\nAcide ascorbique (Acide ascorbique)\r\nVitamine B6\r\nAcide d-pantothénique (D-pantothénate de calcium)\r\nNicotinamide\r\nVitanine B2\r\nVitamine B1\r\nBétacarotène",
    "drug_strength": "300MG\r\n600UNIT\r\n12MCG\r\n1.1MG\r\n15MG\r\n50MG\r\n35MG\r\n0.15MG\r\n2MG\r\n13.8MG\r\n120MG\r\n10MG\r\n5MG\r\n20MG\r\n3.4MG\r\n3MG\r\n1.6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244478,
    "drug": {
      "current_status": "MARKETED",
      "id": 104362,
      "drug_code": 102618,
      "updated_date": "2023-11-16T02:18:28-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8268068,
          "ingredient": {
            "id": 6335,
            "ingredient_code": 11079,
            "en_name": "BETA-CAROTENE",
            "fr_name": "Bétacarotène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268067,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268066,
          "ingredient": {
            "id": 912,
            "ingredient_code": 582,
            "en_name": "COPPER",
            "fr_name": "Cuivre ((FR) COPPER OXIDE)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268065,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268064,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268063,
          "ingredient": {
            "id": 1316,
            "ingredient_code": 6487,
            "en_name": "MAGNESIUM",
            "fr_name": "Magnésium (Chlorure de magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268062,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268061,
          "ingredient": {
            "id": 758,
            "ingredient_code": 5000,
            "en_name": "D-PANTOTHENIC ACID",
            "fr_name": "Acide d-pantothénique (D-pantothénate de calcium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268060,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268059,
          "ingredient": {
            "id": 618,
            "ingredient_code": 7218,
            "en_name": "IODINE",
            "fr_name": "Iode"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268058,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268057,
          "ingredient": {
            "id": 506,
            "ingredient_code": 309,
            "en_name": "IRON",
            "fr_name": "Fer (Complexe fer-dextran)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268056,
          "ingredient": {
            "id": 1310,
            "ingredient_code": 4803,
            "en_name": "CALCIUM",
            "fr_name": "Calcium (Chlorure de calcium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268055,
          "ingredient": {
            "id": 1634,
            "ingredient_code": 11169,
            "en_name": "VITAMIN B6",
            "fr_name": "Vitamine B6"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268054,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "13.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268053,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8268052,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02537478",
      "brand_name": "PREGNANCY MULTIVITAMIN FOLIC 5",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "17",
      "ai_group_no": "1747661006"
    },
    "created_date": "2024-12-02T21:01:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02537478",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "B03AE",
    "atc_description": "IRON PREPARATIONS",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-12T17:51:46-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PREGNANCY MULTIVITAMIN FOLIC 5",
    "en_drug_common_name": "Vitamin-Mineral Supplement Tablets High Dose Folic Acid for Prenatal Use",
    "fr_drug_brand_name": "Multivitamines Maternité Folique 5",
    "fr_drug_common_name": "Supplément vitaminique-minéral en comprimés à dose élevée d’acide folique pour usage prénatal",
    "en_ingredients": "D-PANTOTHENIC ACID\r\nNICOTINAMIDE\r\nVITAMIN B2\r\nVITAMIN B1\r\nCALCIUM\r\nVITAMIN D3\r\nVITAMIN B12\r\nZINC\r\nMAGNESIUM\r\nIODINE\r\nCOPPER\r\nASCORBIC ACID\r\nVITAMIN B6\r\nIRON\r\nVITAMIN E\r\nFOLIC ACID\r\nBETA-CAROTENE",
    "fr_ingredients": "Acide d-pantothénique (D-pantothénate de calcium)\r\nNicotinamide\r\nVitanine B2\r\nVitamine B1\r\nCalcium (Gluconate de calcium)\r\nVitamine D3\r\nVitamine B12 (Cyanocobalamine)\r\nZinc (Oxyde de zinc, Sulfate de zinc)\r\nMagnésium (Chlorure de magnésium)\r\nIode\r\nCuivre\r\nAcide ascorbique (Acide ascorbique)\r\nVitamine B6\r\nFer (Complexe fer-dextran)\r\nVitamine E (Acétate de DL-alpha-tocophérol)\r\nAcide folique\r\nBétacarotène",
    "drug_strength": "5MG\r\n20MG\r\n3.4MG\r\n3MG\r\n300MG\r\n600UNIT\r\n12MCG\r\n15MG\r\n50MG\r\n0.15MG\r\n2MG\r\n120MG\r\n10MG\r\n35MG\r\n13.8MG\r\n5MG\r\n1.6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244481,
    "drug": {
      "current_status": "MARKETED",
      "id": 53509,
      "drug_code": 95474,
      "updated_date": "2025-05-15T02:35:57-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262621,
          "ingredient": {
            "id": 1120,
            "ingredient_code": 10196,
            "en_name": "NITROFURANTOIN",
            "fr_name": "Nitrofurantoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466392",
      "brand_name": "AURO-NITROFURANTOIN BID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101480001"
    },
    "created_date": "2024-12-02T21:27:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466392",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01XE",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2025-02-07T00:00:00-05:00",
    "actual_start_date": "2025-01-15T00:00:00-05:00",
    "actual_end_date": "2025-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-07T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Please look for stocks available at wholesalers.",
    "fr_comments": "veuillez rechercher les stocks disponibles chez les grossistes",
    "en_drug_brand_name": "AURO-NITROFURANTOIN BID",
    "en_drug_common_name": "Auro-Nitrofurantoin BID 100mg Caps 100 Btl",
    "fr_drug_brand_name": "Auro-Nitrofurantoin",
    "fr_drug_common_name": "Auro-Nitrofurantoin",
    "en_ingredients": "NITROFURANTOIN",
    "fr_ingredients": "Nitrofurantoïne",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244619,
    "drug": {
      "current_status": "MARKETED",
      "id": 10598,
      "drug_code": 66188,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254015,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242463",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2024-12-03T20:29:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242463",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2024-12-20T00:00:00-05:00",
    "estimated_end_date": "2025-01-15T00:00:00-05:00",
    "actual_start_date": "2024-12-20T00:00:00-05:00",
    "actual_end_date": "2025-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-21T18:41:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244622,
    "drug": {
      "current_status": "MARKETED",
      "id": 14240,
      "drug_code": 74319,
      "updated_date": "2025-12-03T00:31:00-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255136,
          "ingredient": {
            "id": 2430,
            "ingredient_code": 5044,
            "en_name": "ISOTRETINOIN",
            "fr_name": "Isotrétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257955",
      "brand_name": "CLARUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115751001"
    },
    "created_date": "2024-12-03T20:31:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257955",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D10BA",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE",
    "anticipated_start_date": "2024-12-30T00:00:00-05:00",
    "actual_end_date": "2025-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-07T16:02:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLARUS",
    "en_drug_common_name": "ISOTRETINOIN",
    "fr_drug_brand_name": "CLARUS",
    "fr_drug_common_name": "ISOTRETINOIN",
    "en_ingredients": "ISOTRETINOIN",
    "fr_ingredients": "Isotrétinoïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244642,
    "drug": {
      "current_status": "MARKETED",
      "id": 32068,
      "drug_code": 9611,
      "updated_date": "2025-05-15T02:30:46-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251199,
          "ingredient": {
            "id": 1334,
            "ingredient_code": 4028,
            "en_name": "SODIUM POLYSTYRENE SULFONATE",
            "fr_name": "Polystyrène sulfonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00769541",
      "brand_name": "SOLYSTAT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68821",
      "number_of_ais": "1",
      "ai_group_no": "0108701001"
    },
    "created_date": "2024-12-03T22:11:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00769541",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "V03AE",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2024-12-02T00:00:00-05:00",
    "estimated_end_date": "2025-02-21T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-24T16:40:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SOLYSTAT",
    "en_drug_common_name": "Solystat",
    "fr_drug_brand_name": "Solystat",
    "fr_drug_common_name": "Solystat",
    "en_ingredients": "SODIUM POLYSTYRENE SULFONATE",
    "fr_ingredients": "Polystyrène sulfonate de sodium",
    "drug_strength": "250MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244645,
    "drug": {
      "current_status": "MARKETED",
      "id": 6582,
      "drug_code": 43536,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253104,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229315",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9877",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2024-12-03T22:14:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229315",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2024-12-24T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-09T13:52:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "PDP-DESONIDE",
    "fr_drug_brand_name": "Desonide",
    "fr_drug_common_name": "Desonide",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244732,
    "drug": {
      "current_status": "MARKETED",
      "id": 55854,
      "drug_code": 95481,
      "updated_date": "2025-05-15T02:35:57-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262628,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466457",
      "brand_name": "BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2024-12-04T13:09:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466457",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-04T13:10:04-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE",
    "fr_drug_brand_name": "BETAHISTINE",
    "fr_drug_common_name": "BETAHISTINE",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244743,
    "drug": {
      "current_status": "MARKETED",
      "id": 3538,
      "drug_code": 18877,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 344,
        "created_date": "2017-03-09T13:22:42-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 8060,
        "mfr_code": "",
        "name": "ETHYPHARM INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 1500",
        "street_name": "1200 AVENUE MCGILL COLLEGE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3B 4G7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252396,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02177757",
      "brand_name": "M-ESLON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81157",
      "number_of_ais": "1",
      "ai_group_no": "0104545013"
    },
    "created_date": "2024-12-04T14:15:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02177757",
    "company_name": "ETHYPHARM INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2024-12-04T00:00:00-05:00",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2024-12-05T00:00:00-05:00",
    "actual_end_date": "2024-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-16T12:55:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-ESLON",
    "en_drug_common_name": "Morphine Sulfate",
    "fr_drug_brand_name": "NM-ESLON®",
    "fr_drug_common_name": "sulfate de morphine en capsules à libération prolongée",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "200 mg",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244817,
    "drug": {
      "current_status": "MARKETED",
      "id": 3298,
      "drug_code": 18349,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252303,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02009013",
      "brand_name": "ASAPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80578",
      "number_of_ais": "1",
      "ai_group_no": "0101169013"
    },
    "created_date": "2024-12-04T23:53:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02009013",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2025-02-21T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-18T15:44:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ASAPHEN",
    "en_drug_common_name": "ASAPHEN CHEW",
    "fr_drug_brand_name": "ASAPHEN CHEW",
    "fr_drug_common_name": "ASAPHEN",
    "en_ingredients": "ACETYLSALICYLIC ACID",
    "fr_ingredients": "Acide acétylsalicylique",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244822,
    "drug": {
      "current_status": "MARKETED",
      "id": 7660,
      "drug_code": 50551,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253369,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231244",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "1ML UNIT DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2024-12-05T00:05:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231244",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2025-01-08T00:00:00-05:00",
    "actual_start_date": "2024-12-04T00:00:00-05:00",
    "actual_end_date": "2025-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-15T13:39:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "pms-IPRATROPIUM",
    "fr_drug_brand_name": "pms-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20X1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244825,
    "drug": {
      "current_status": "MARKETED",
      "id": 18994,
      "drug_code": 80257,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256648,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317060",
      "brand_name": "PMS-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2024-12-05T00:10:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317060",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-01-06T00:00:00-05:00",
    "actual_start_date": "2024-12-04T00:00:00-05:00",
    "actual_end_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T15:28:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IRBESARTAN",
    "en_drug_common_name": "pms-IRBESARTAN",
    "fr_drug_brand_name": "pms-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244858,
    "drug": {
      "current_status": "MARKETED",
      "id": 63440,
      "drug_code": 97385,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 1786,
        "created_date": "2017-03-09T13:25:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16778,
        "mfr_code": "",
        "name": "GLENMARK PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 STEELES AVE. W., SUITE 407",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "CONCORD",
        "postal_code": "L4K 4M2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263760,
          "ingredient": {
            "id": 1124,
            "ingredient_code": 1832,
            "en_name": "MUPIROCIN",
            "fr_name": "Mupirocine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02483459",
      "brand_name": "STRAMUCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117081001"
    },
    "created_date": "2024-12-05T15:44:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483459",
    "company_name": "GLENMARK PHARMACEUTICALS CANADA INC.",
    "atc_number": "D06AX",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "anticipated_start_date": "2024-12-06T00:00:00-05:00",
    "estimated_end_date": "2025-02-17T00:00:00-05:00",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "actual_end_date": "2025-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2025-03-17T17:18:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STRAMUCIN",
    "en_drug_common_name": "STRAMUCIN",
    "fr_drug_brand_name": "STRAMUCIN",
    "fr_drug_common_name": "STRAMUCIN",
    "en_ingredients": "MUPIROCIN",
    "fr_ingredients": "Mupirocine",
    "drug_strength": "2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244865,
    "drug": {
      "current_status": "MARKETED",
      "id": 20886,
      "drug_code": 82836,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8257391,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02342863",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2024-12-05T15:56:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02342863",
    "company_name": "STERIMAX INC",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2024-12-20T00:00:00-05:00",
    "actual_start_date": "2024-12-05T00:00:00-05:00",
    "actual_end_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Inventory remains at McKesson.",
    "fr_comments": "Inventaire est disponible chez McKesson.",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP",
    "en_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP",
    "fr_drug_brand_name": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION USP",
    "fr_drug_common_name": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Vancomycine (Chlorhydrate de vancomycine)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244883,
    "drug": {
      "current_status": "MARKETED",
      "id": 16170,
      "drug_code": 76961,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255769,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284049",
      "brand_name": "APO-DESMOPRESSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050003"
    },
    "created_date": "2024-12-05T16:17:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284049",
    "company_name": "APOTEX INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-31T16:18:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESMOPRESSIN",
    "en_drug_common_name": "DESMOPRESSIN",
    "fr_drug_brand_name": "APO-DESMOPRESSIN",
    "fr_drug_common_name": "DESMOPRESSIN",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244888,
    "drug": {
      "current_status": "MARKETED",
      "id": 61186,
      "drug_code": 95755,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262794,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "110",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468905",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467002"
    },
    "created_date": "2024-12-05T16:18:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468905",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-01-24T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-24T16:00:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "Dabigatran étexilate (Mésilate de dabigatran étexilate)",
    "drug_strength": "110MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244890,
    "drug": {
      "current_status": "MARKETED",
      "id": 59313,
      "drug_code": 96892,
      "updated_date": "2025-05-15T02:36:34-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263413,
          "ingredient": {
            "id": 3686,
            "ingredient_code": 20636,
            "en_name": "LACOSAMIDE",
            "fr_name": "Lacosamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02478196",
      "brand_name": "PHARMA-LACOSAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152810001"
    },
    "created_date": "2024-12-05T16:18:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02478196",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2025-01-08T00:00:00-05:00",
    "actual_start_date": "2024-12-05T00:00:00-05:00",
    "actual_end_date": "2025-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-09T20:21:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMA-LACOSAMIDE",
    "en_drug_common_name": "pharma-LACOSAMIDE",
    "fr_drug_brand_name": "pharma-LACOSAMIDE",
    "fr_drug_common_name": "LACOSAMIDE",
    "en_ingredients": "LACOSAMIDE",
    "fr_ingredients": "Lacosamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244896,
    "drug": {
      "current_status": "MARKETED",
      "id": 16846,
      "drug_code": 77827,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255947,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292920",
      "brand_name": "APO-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2024-12-05T16:19:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292920",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2025-02-21T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-14T19:58:31-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "APO-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "Pantoprazole (Pantoprazole sodique sesquihydrate)",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244899,
    "drug": {
      "current_status": "MARKETED",
      "id": 22294,
      "drug_code": 84693,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257976,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361892",
      "brand_name": "PMS-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-12-05T16:25:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361892",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-01-22T00:00:00-05:00",
    "actual_start_date": "2024-12-05T00:00:00-05:00",
    "actual_end_date": "2025-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-23T13:34:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "pms-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244902,
    "drug": {
      "current_status": "MARKETED",
      "id": 19046,
      "drug_code": 80310,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256668,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317575",
      "brand_name": "SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "DIAMOND-SHAPED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261002"
    },
    "created_date": "2024-12-05T16:28:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317575",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2025-01-08T00:00:00-05:00",
    "actual_start_date": "2024-12-05T00:00:00-05:00",
    "actual_end_date": "2025-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-09T20:19:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "Sildénafil (Citrate de sildénafil)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1X4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244907,
    "drug": {
      "current_status": "MARKETED",
      "id": 20712,
      "drug_code": 82498,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8257329,
          "ingredient": {
            "id": 3622,
            "ingredient_code": 20565,
            "en_name": "DEXMEDETOMIDINE",
            "fr_name": "Dexmédétomidine (Chlorhydrate de dexmédétomidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02339366",
      "brand_name": "PRECEDEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152679003"
    },
    "created_date": "2024-12-05T18:33:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339366",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2024-11-29T00:00:00-05:00",
    "actual_end_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRECEDEX",
    "en_drug_common_name": "PRECEDEX",
    "fr_drug_brand_name": "PRECEDEX",
    "fr_drug_common_name": "PRECEDEX",
    "en_ingredients": "DEXMEDETOMIDINE",
    "fr_ingredients": "Dexmédétomidine (Chlorhydrate de dexmédétomidine)",
    "drug_strength": "100MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25X2 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244910,
    "drug": {
      "current_status": "MARKETED",
      "id": 28210,
      "drug_code": 90347,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260237,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418932",
      "brand_name": "APO-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2024-12-05T19:01:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418932",
    "company_name": "APOTEX INC",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2025-02-07T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-24T16:02:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "APO-CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244915,
    "drug": {
      "current_status": "MARKETED",
      "id": 56778,
      "drug_code": 95586,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262687,
          "ingredient": {
            "id": 3486,
            "ingredient_code": 11359,
            "en_name": "CEFEPIME",
            "fr_name": "Céfépime (Chlorhydrate de céfépime)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02467496",
      "brand_name": "APO-CEFEPIME",
      "brand_name_fr": "APO-CEFEPIME",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150504004"
    },
    "created_date": "2024-12-05T19:02:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467496",
    "company_name": "APOTEX INC",
    "atc_number": "J01DE",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2025-02-14T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-14T19:55:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFEPIME",
    "en_drug_common_name": "CEFEPIME",
    "fr_drug_brand_name": "APO-CEFEPIME",
    "fr_drug_common_name": "CEFEPIME",
    "en_ingredients": "CEFEPIME",
    "fr_ingredients": "Céfépime (Chlorhydrate de céfépime)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244918,
    "drug": {
      "current_status": "MARKETED",
      "id": 103962,
      "drug_code": 102496,
      "updated_date": "2023-06-19T23:14:00-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8267960,
          "ingredient": {
            "id": 4026,
            "ingredient_code": 22549,
            "en_name": "DAPAGLIFLOZIN",
            "fr_name": "Dapagliflozine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8267959,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02536153",
      "brand_name": "APO-DAPAGLIFLOZIN-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257650001"
    },
    "created_date": "2024-12-05T19:03:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02536153",
    "company_name": "APOTEX INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2024-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-13T15:11:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DAPAGLIFLOZIN-METFORMIN",
    "en_drug_common_name": "DAPAGLIFLOZIN-METFORMIN",
    "fr_drug_brand_name": "APO-DAPAGLIFLOZIN-METFORMIN",
    "fr_drug_common_name": "DAPAGLIFLOZIN-METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nDAPAGLIFLOZIN",
    "fr_ingredients": "Chlorhydrate de metformine\r\nDapagliflozine",
    "drug_strength": "850MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244922,
    "drug": {
      "current_status": "MARKETED",
      "id": 102686,
      "drug_code": 101280,
      "updated_date": "2022-02-08T06:12:45-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8266861,
          "ingredient": {
            "id": 3870,
            "ingredient_code": 22124,
            "en_name": "GUANFACINE",
            "fr_name": "Guanfacine (Chlorhydrate de guanfacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02523744",
      "brand_name": "APO-GUANFACINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154470003"
    },
    "created_date": "2024-12-05T19:04:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02523744",
    "company_name": "APOTEX INC",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-17T21:39:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GUANFACINE XR",
    "en_drug_common_name": "GUANFACINE XR",
    "fr_drug_brand_name": "APO-GUANFACINE XR",
    "fr_drug_common_name": "GUANFACINE XR",
    "en_ingredients": "GUANFACINE",
    "fr_ingredients": "Guanfacine (Chlorhydrate de guanfacine)",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244926,
    "drug": {
      "current_status": "MARKETED",
      "id": 8402,
      "drug_code": 5823,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250837,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00628123",
      "brand_name": "APO-AMOXI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61601",
      "number_of_ais": "1",
      "ai_group_no": "0131314006"
    },
    "created_date": "2024-12-05T19:05:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00628123",
    "company_name": "APOTEX INC",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-03T00:00:00-05:00",
    "actual_end_date": "2025-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T18:14:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI",
    "en_drug_common_name": "AMOXI",
    "fr_drug_brand_name": "APO-AMOXI",
    "fr_drug_common_name": "AMOXI",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline (Trihydrate d'amoxicilline)",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244980,
    "drug": {
      "current_status": "MARKETED",
      "id": 546,
      "drug_code": 11153,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251476,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00443816",
      "brand_name": "RETIN-A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71653",
      "number_of_ais": "1",
      "ai_group_no": "0112395002"
    },
    "created_date": "2024-12-05T20:32:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00443816",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2025-01-27T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-01-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-29T18:16:10-05:00",
    "status": "resolved",
    "en_comments": "delay in production",
    "fr_comments": "délai en production",
    "en_drug_brand_name": "RETIN-A",
    "en_drug_common_name": "RETIN-A",
    "fr_drug_brand_name": "RETIN-A",
    "fr_drug_common_name": "RETIN-A",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.025%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244985,
    "drug": {
      "current_status": "MARKETED",
      "id": 2858,
      "drug_code": 16903,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252173,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252172,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045737",
      "brand_name": "ZESTORETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78973",
      "number_of_ais": "2",
      "ai_group_no": "0222417001"
    },
    "created_date": "2024-12-05T20:36:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045737",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2024-11-01T00:00:00-04:00",
    "estimated_end_date": "2026-01-01T00:00:00-05:00",
    "actual_start_date": "2024-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-26T21:47:10-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ZESTORETIC",
    "en_drug_common_name": "Zestoretic 20/12.5",
    "fr_drug_brand_name": "Zestoretic",
    "fr_drug_common_name": "Zestoretic 20/12.5",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLISINOPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nLisinopril",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244988,
    "drug": {
      "current_status": "MARKETED",
      "id": 2922,
      "drug_code": 17126,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252187,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02049333",
      "brand_name": "ZESTRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79276",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2024-12-05T20:41:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02049333",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2024-10-08T00:00:00-04:00",
    "estimated_end_date": "2026-01-01T00:00:00-05:00",
    "actual_start_date": "2024-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-26T21:48:50-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ZESTRIL",
    "en_drug_common_name": "Zestril 5MG",
    "fr_drug_brand_name": "Zestril",
    "fr_drug_common_name": "Zestril 5MG",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 244991,
    "drug": {
      "current_status": "MARKETED",
      "id": 5310,
      "drug_code": 3429,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250513,
          "ingredient": {
            "id": 1938,
            "ingredient_code": 4893,
            "en_name": "CALCITRIOL",
            "fr_name": "Calcitriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00481815",
      "brand_name": "ROCALTROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54334",
      "number_of_ais": "1",
      "ai_group_no": "0113628005"
    },
    "created_date": "2024-12-05T20:48:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00481815",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "anticipated_start_date": "2024-11-01T00:00:00-04:00",
    "estimated_end_date": "2026-01-01T00:00:00-05:00",
    "actual_start_date": "2024-11-01T00:00:00-04:00",
    "actual_end_date": "2025-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROCALTROL",
    "en_drug_common_name": "Rocaltrol 0.5MCG",
    "fr_drug_brand_name": "Rocaltrol",
    "fr_drug_common_name": "Rocaltrol 0.5MCG",
    "en_ingredients": "CALCITRIOL",
    "fr_ingredients": "Calcitriol",
    "drug_strength": "0.5MCG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 capsules",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245021,
    "drug": {
      "current_status": "MARKETED",
      "id": 51281,
      "drug_code": 94883,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262335,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461323",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2024-12-06T16:07:53-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02461323",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE MR",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60MRT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245024,
    "drug": {
      "current_status": "MARKETED",
      "id": 51281,
      "drug_code": 94883,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262335,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461323",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2024-12-06T16:09:09-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02461323",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE MR",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245027,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2024-12-06T16:10:22-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE MR",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60MRT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245030,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2024-12-06T16:11:38-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE MR",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245033,
    "drug": {
      "current_status": "MARKETED",
      "id": 100070,
      "drug_code": 98290,
      "updated_date": "2020-04-03T06:54:21-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264485,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02492911",
      "brand_name": "SANDOZ EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2024-12-06T16:46:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02492911",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AH",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "actual_end_date": "2024-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-17T06:00:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ EVEROLIMUS",
    "en_drug_common_name": "EVEROLIMUS",
    "fr_drug_brand_name": "SANDOZ EVEROLIMUS",
    "fr_drug_common_name": "EVEROLIMUS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245052,
    "drug": {
      "current_status": "MARKETED",
      "id": 20734,
      "drug_code": 82518,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257342,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02339587",
      "brand_name": "ACH-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541002"
    },
    "created_date": "2024-12-06T20:55:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339587",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "ACH Pioglitazone",
    "fr_drug_common_name": "Pioglitazone",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "Pioglitazone (Chlorhydrate de pioglitazone)",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245057,
    "drug": {
      "current_status": "MARKETED",
      "id": 20736,
      "drug_code": 82519,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257343,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02339595",
      "brand_name": "ACH-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2024-12-06T21:05:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339595",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "ACH Pioglitazone",
    "fr_drug_common_name": "Pioglitazone",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "Pioglitazone (Chlorhydrate de pioglitazone)",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245060,
    "drug": {
      "current_status": "MARKETED",
      "id": 21642,
      "drug_code": 84031,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257733,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355043",
      "brand_name": "ACH-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2024-12-06T21:07:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355043",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "ACH Finastéride",
    "fr_drug_common_name": "Finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245063,
    "drug": {
      "current_status": "MARKETED",
      "id": 23850,
      "drug_code": 86515,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258583,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379279",
      "brand_name": "ACH-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2024-12-06T21:08:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379279",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "ACH Candésartan",
    "fr_drug_common_name": "Candésartan",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245066,
    "drug": {
      "current_status": "MARKETED",
      "id": 66077,
      "drug_code": 92501,
      "updated_date": "2025-05-15T02:34:46-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261123,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440644",
      "brand_name": "ACH-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2024-12-06T21:08:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440644",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "ACH Pravastatine",
    "fr_drug_common_name": "Pravastatine",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245069,
    "drug": {
      "current_status": "MARKETED",
      "id": 67159,
      "drug_code": 92503,
      "updated_date": "2020-04-03T06:02:06-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261125,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440660",
      "brand_name": "ACH-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2024-12-06T21:09:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440660",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-07T06:00:03-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "ACH Pravastatine",
    "fr_drug_common_name": "Pravastatine",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245072,
    "drug": {
      "current_status": "MARKETED",
      "id": 31048,
      "drug_code": 93200,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8261480,
          "ingredient": {
            "id": 3406,
            "ingredient_code": 20155,
            "en_name": "FLUTICASONE FUROATE",
            "fr_name": "Furoate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02446561",
      "brand_name": "ARNUITY ELLIPTA",
      "brand_name_fr": "ARNUITY ELLIPTA",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152271002"
    },
    "created_date": "2024-12-06T21:32:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446561",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "actual_start_date": "2024-12-04T00:00:00-05:00",
    "actual_end_date": "2024-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-21T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ARNUITY ELLIPTA",
    "en_drug_common_name": "fluticasone furoate dry powder for oral inhalation",
    "fr_drug_brand_name": "ARNUITY ELLIPTA",
    "fr_drug_common_name": "furoate de fluticasone en poudre sèche pour inhalation par voie orale",
    "en_ingredients": "FLUTICASONE FUROATE",
    "fr_ingredients": "Furoate de fluticasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245107,
    "drug": {
      "current_status": "MARKETED",
      "id": 59695,
      "drug_code": 90686,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8260365,
          "ingredient": {
            "id": 16019,
            "ingredient_code": 20484,
            "en_name": "TETROFOSMIN",
            "fr_name": "Tétrofosmine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.38",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02422158",
      "brand_name": "MYOVIEW 30ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152605002"
    },
    "created_date": "2024-12-09T15:07:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422158",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09GA",
    "estimated_end_date": "2025-01-02T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2024-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-12-31T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Reason for shortage: testing delays",
    "fr_comments": "Raison de la pénurie: Délais d'analyse",
    "en_drug_brand_name": "MYOVIEW 30ML",
    "en_drug_common_name": "Kit for the Preparation of Technetium-99m Tetrofosmin Injection",
    "fr_drug_brand_name": "Myoview 30 mL",
    "fr_drug_common_name": "Trousse de préparation de la tétrofosmine marquée au technétium 99m (99mTc) pour injection",
    "en_ingredients": "TETROFOSMIN",
    "fr_ingredients": "Tétrofosmine",
    "drug_strength": "1.38MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 kit package",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245118,
    "drug": {
      "current_status": "MARKETED",
      "id": 21336,
      "drug_code": 8374,
      "updated_date": "2025-12-03T00:30:25-05:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251082,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00755583",
      "brand_name": "TEGRETOL CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66804",
      "number_of_ais": "1",
      "ai_group_no": "0108674004"
    },
    "created_date": "2024-12-09T16:29:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00755583",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2025-01-22T00:00:00-05:00",
    "estimated_end_date": "2025-02-02T00:00:00-05:00",
    "actual_end_date": "2025-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-05T13:40:22-05:00",
    "status": "resolved",
    "en_comments": "Product on allocation to minimize patient impact.",
    "fr_comments": "Produit alloué pour minimiser l’impact sur le patient.",
    "en_drug_brand_name": "TEGRETOL CR",
    "en_drug_common_name": "TEGRETOL CR 400MG TABS 100'S",
    "fr_drug_brand_name": "TEGRETOL CR",
    "fr_drug_common_name": "TEGRETOL CR 400MG TABS 100'S",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245141,
    "drug": {
      "current_status": "MARKETED",
      "id": 8142,
      "drug_code": 5402,
      "updated_date": "2025-05-15T02:30:33-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250751,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00533688",
      "brand_name": "TOBRAMYCIN FOR INJECTION",
      "brand_name_fr": "TOBRAMYCINE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60581",
      "number_of_ais": "1",
      "ai_group_no": "0110230006"
    },
    "created_date": "2024-12-09T21:49:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00533688",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "anticipated_start_date": "2024-12-10T00:00:00-05:00",
    "estimated_end_date": "2025-01-24T00:00:00-05:00",
    "actual_end_date": "2025-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-22T15:36:10-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that we will be encountering a supply interruption on our Tobramycin for Injection 1.2 g PBP Vial 50 mL effective December 10, 2024, until January 24, 2025.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer que notre présentation de Tobramycine pour injection 1,2 g, flacon GFP, 50 mL sera en situation d’interruption d’approvisionnement du 10 décembre 2024 au 24 janvier 2025.",
    "en_drug_brand_name": "TOBRAMYCIN FOR INJECTION",
    "en_drug_common_name": "TOBRAMYCIN FOR INJECTION",
    "fr_drug_brand_name": "Tobramycine pour injection",
    "fr_drug_common_name": "Tobramycine pour injection",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine (Sulfate de tobramycine)",
    "drug_strength": "1.2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245161,
    "drug": {
      "current_status": "MARKETED",
      "id": 31108,
      "drug_code": 93276,
      "updated_date": "2025-05-15T02:35:07-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261501,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02447193",
      "brand_name": "BIO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2024-12-10T14:08:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02447193",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-10T14:08:43-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "BIO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245164,
    "drug": {
      "current_status": "MARKETED",
      "id": 31204,
      "drug_code": 93412,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261561,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448432",
      "brand_name": "BIO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2024-12-10T14:12:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448432",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2024-06-21T00:00:00-04:00",
    "estimated_end_date": "2025-03-07T00:00:00-05:00",
    "actual_start_date": "2024-06-21T00:00:00-04:00",
    "actual_end_date": "2025-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-20T19:17:30-04:00",
    "status": "resolved",
    "en_comments": "Pénurie liée au respect des BPFs par le fournisseur du produit",
    "en_drug_brand_name": "BIO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxétine (Chlorhydrate de fluoxétine)",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245167,
    "drug": {
      "current_status": "MARKETED",
      "id": 31202,
      "drug_code": 93411,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261560,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448424",
      "brand_name": "BIO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2024-12-10T14:14:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448424",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-03-07T00:00:00-05:00",
    "actual_start_date": "2024-12-06T00:00:00-05:00",
    "actual_end_date": "2025-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-20T19:16:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxétine (Chlorhydrate de fluoxétine)",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245202,
    "drug": {
      "current_status": "MARKETED",
      "id": 103211,
      "drug_code": 97931,
      "updated_date": "2022-10-08T04:04:56-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264171,
          "ingredient": {
            "id": 3764,
            "ingredient_code": 21078,
            "en_name": "APIXABAN",
            "fr_name": "Apixaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489236",
      "brand_name": "SANDOZ APIXABAN SDZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153051002"
    },
    "created_date": "2024-12-10T15:35:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489236",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-21T06:00:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ APIXABAN SDZ",
    "en_drug_common_name": "APIXABAN",
    "fr_drug_brand_name": "SANDOZ APIXABAN",
    "fr_drug_common_name": "APIXABAN",
    "en_ingredients": "APIXABAN",
    "fr_ingredients": "Apixaban",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245205,
    "drug": {
      "current_status": "MARKETED",
      "id": 15768,
      "drug_code": 76502,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255643,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279436",
      "brand_name": "ONDANSETRON INJECTION USP   -(WITH PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120004"
    },
    "created_date": "2024-12-10T15:36:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279436",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-22T12:47:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE)",
    "en_drug_common_name": "ONDANSETRON  injection",
    "fr_drug_brand_name": "SANDOZ ONDANSETRON  injection",
    "fr_drug_common_name": "ONDANSETRON  injection",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245208,
    "drug": {
      "current_status": "MARKETED",
      "id": 17458,
      "drug_code": 78500,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256150,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8256149,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02299623",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919004"
    },
    "created_date": "2024-12-10T15:38:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299623",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:45:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN AND TAZOBACTAM",
    "fr_drug_brand_name": "SANDOZ PIPERACILLIN AND TAZOBACTAM",
    "fr_drug_common_name": "PIPERACILLIN AND TAZOBACTAM",
    "en_ingredients": "TAZOBACTAM\r\nPIPERACILLIN",
    "fr_ingredients": "Tazobactam (Tazobactam sodique)\r\nPipéracilline (Pipéracilline sodique)",
    "drug_strength": "0.25G\r\n2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10PSOIJ",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245211,
    "drug": {
      "current_status": "MARKETED",
      "id": 104421,
      "drug_code": 102663,
      "updated_date": "2023-12-19T01:01:32-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8268101,
          "ingredient": {
            "id": 3482,
            "ingredient_code": 20387,
            "en_name": "RIVAROXABAN",
            "fr_name": "Rivaroxaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02537877",
      "brand_name": "SANDOZ RIVAROXABAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152487004"
    },
    "created_date": "2024-12-10T15:39:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02537877",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-06-06T00:00:00-04:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-06-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RIVAROXABAN",
    "en_drug_common_name": "RIVAROXABAN",
    "fr_drug_brand_name": "SANDOZ RIVAROXABAN",
    "fr_drug_common_name": "RIVAROXABAN",
    "en_ingredients": "RIVAROXABAN",
    "fr_ingredients": "Rivaroxaban",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245214,
    "drug": {
      "current_status": "MARKETED",
      "id": 57520,
      "drug_code": 81110,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256901,
          "ingredient": {
            "id": 2414,
            "ingredient_code": 11443,
            "en_name": "TRANDOLAPRIL",
            "fr_name": "Trandolapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325748",
      "brand_name": "SANDOZ TRANDOLAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131524002"
    },
    "created_date": "2024-12-10T15:41:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325748",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2025-03-28T00:00:00-04:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-01T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "en_drug_common_name": "TRANDOLAPRIL",
    "fr_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "fr_drug_common_name": "TRANDOLAPRIL",
    "en_ingredients": "TRANDOLAPRIL",
    "fr_ingredients": "Trandolapril",
    "drug_strength": "1MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245217,
    "drug": {
      "current_status": "MARKETED",
      "id": 57787,
      "drug_code": 95718,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262775,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468700",
      "brand_name": "SANDOZ PRAVASTATIN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2024-12-10T15:42:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468700",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2024-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-17T06:00:21-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "SANDOZ PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245230,
    "drug": {
      "current_status": "MARKETED",
      "id": 102370,
      "drug_code": 100301,
      "updated_date": "2021-11-08T05:00:22-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266176,
          "ingredient": {
            "id": 3848,
            "ingredient_code": 22048,
            "en_name": "DIMETHYL FUMARATE",
            "fr_name": "Fumarate de diméthyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02513803",
      "brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154210002"
    },
    "created_date": "2024-12-10T17:19:07-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02513803",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AX",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "en_drug_common_name": "DIMETHYL FUM SDZ",
    "fr_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "fr_drug_common_name": "DIMETHYL FUM SDZ",
    "en_ingredients": "DIMETHYL FUMARATE",
    "fr_ingredients": "Fumarate de diméthyle",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56GRC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245261,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13906,
      "drug_code": 73859,
      "updated_date": "2025-05-15T04:08:42-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8339991,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        },
        {
          "id": 8339990,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02253631",
      "brand_name": "TEVETEN PLUS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250121001"
    },
    "created_date": "2024-12-10T18:05:26-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02253631",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2023-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Discontinued 2023-08-30-The last lots and expiry dates are 711407/31-Aug-2022 - Reported in shortage ID 169169",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-12-10T18:05:38-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVETEN PLUS",
    "en_drug_common_name": "EPROSARTAN",
    "fr_drug_brand_name": "EPROSARTAN",
    "fr_drug_common_name": "EPROSARTAN",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nEPROSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nÉprosartan (Mésylate d'éprosartan)",
    "drug_strength": "12.5MG\r\n600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245264,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24736,
      "drug_code": 87304,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351705,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02387468",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2024-12-10T18:09:07-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02387468",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2023-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-12-10T18:09:45-05:00",
    "status": "discontinued",
    "hc_en_comments": "Discontinued 2023-01-10-The last lots and expiry dates are 760813/31-Jan-2018 - Reported in shortage ID 78454",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "fr_drug_common_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20ML 1VL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245267,
    "drug": {
      "current_status": "MARKETED",
      "id": 102369,
      "drug_code": 100300,
      "updated_date": "2021-11-08T05:00:22-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266175,
          "ingredient": {
            "id": 3848,
            "ingredient_code": 22048,
            "en_name": "DIMETHYL FUMARATE",
            "fr_name": "Fumarate de diméthyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02513781",
      "brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154210001"
    },
    "created_date": "2024-12-10T18:10:17-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02513781",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AX",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "en_drug_common_name": "DIMETHYL FUM SDZ",
    "fr_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "fr_drug_common_name": "DIMETHYL FUM SDZ",
    "en_ingredients": "DIMETHYL FUMARATE",
    "fr_ingredients": "Fumarate de diméthyle",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56GRC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245270,
    "drug": {
      "current_status": "MARKETED",
      "id": 19506,
      "drug_code": 80802,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256815,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02322579",
      "brand_name": "SANDOZ FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2024-12-10T18:12:15-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02322579",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "SANDOZ FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245273,
    "drug": {
      "current_status": "MARKETED",
      "id": 19642,
      "drug_code": 81002,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256860,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324571",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2024-12-10T18:13:52-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324571",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE SDZ",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56HGC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245276,
    "drug": {
      "current_status": "MARKETED",
      "id": 19642,
      "drug_code": 81002,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256860,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324571",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2024-12-10T18:15:09-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324571",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245279,
    "drug": {
      "current_status": "MARKETED",
      "id": 19644,
      "drug_code": 81003,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256861,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324598",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521003"
    },
    "created_date": "2024-12-10T18:17:18-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324598",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245282,
    "drug": {
      "current_status": "MARKETED",
      "id": 19644,
      "drug_code": 81003,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256861,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324598",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521003"
    },
    "created_date": "2024-12-10T18:18:10-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324598",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56HGC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245285,
    "drug": {
      "current_status": "MARKETED",
      "id": 19640,
      "drug_code": 81001,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256859,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324563",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521001"
    },
    "created_date": "2024-12-10T18:20:09-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324563",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245288,
    "drug": {
      "current_status": "MARKETED",
      "id": 19640,
      "drug_code": 81001,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256859,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324563",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521001"
    },
    "created_date": "2024-12-10T18:21:07-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324563",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56HGC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245291,
    "drug": {
      "current_status": "MARKETED",
      "id": 19646,
      "drug_code": 81004,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256862,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324601",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521004"
    },
    "created_date": "2024-12-10T18:22:29-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324601",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:06-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56HGC",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245304,
    "drug": {
      "current_status": "MARKETED",
      "id": 26270,
      "drug_code": 88636,
      "updated_date": "2025-12-03T00:32:12-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259454,
          "ingredient": {
            "id": 2248,
            "ingredient_code": 9407,
            "en_name": "VINBLASTINE SULFATE",
            "fr_name": "Sulfate de vinblastine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02401460",
      "brand_name": "VINBLASTINE SULPHATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103625001"
    },
    "created_date": "2024-12-10T19:41:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401460",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "anticipated_start_date": "2025-02-01T00:00:00-05:00",
    "estimated_end_date": "2025-06-30T00:00:00-04:00",
    "actual_start_date": "2025-02-02T00:00:00-05:00",
    "actual_end_date": "2025-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-24T18:11:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VINBLASTINE SULPHATE INJECTION",
    "en_drug_common_name": "VINBLASTINE SULFATE INJECTION 10MG/10ML",
    "fr_drug_brand_name": "VINBLASTINE SULFATE INJECTION 10MG/10ML",
    "fr_drug_common_name": "VINBLASTINE SULFATE INJECTION 10MG/10ML",
    "en_ingredients": "VINBLASTINE SULFATE",
    "fr_ingredients": "Sulfate de vinblastine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245307,
    "drug": {
      "current_status": "MARKETED",
      "id": 105146,
      "drug_code": 103996,
      "updated_date": "2024-09-11T05:36:12-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8269161,
          "ingredient": {
            "id": 36205,
            "ingredient_code": 24002,
            "en_name": "VORASIDENIB",
            "fr_name": "Vorasidénib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02551225",
      "brand_name": "VORANIGO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0166124001"
    },
    "created_date": "2024-12-10T20:05:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02551225",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "L01X",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2024-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-18T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VORANIGO",
    "en_drug_common_name": "Vorasidenib tablets",
    "fr_drug_brand_name": "Voranigo",
    "fr_drug_common_name": "Vorasidenib tablets",
    "en_ingredients": "VORASIDENIB",
    "fr_ingredients": "Vorasidénib",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245310,
    "drug": {
      "current_status": "MARKETED",
      "id": 10908,
      "drug_code": 66827,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8254110,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242987",
      "brand_name": "DIAMICRON MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2024-12-10T20:10:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242987",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2024-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-13T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DIAMICRON MR",
    "en_drug_common_name": "Gliclazide modified release tablets",
    "fr_drug_brand_name": "Diamicron",
    "fr_drug_common_name": "Gliclazide modified release tablets",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245319,
    "drug": {
      "current_status": "MARKETED",
      "id": 5376,
      "drug_code": 35083,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252833,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "328",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02181746",
      "brand_name": "SODIUM ACETATE INJECTION USP",
      "brand_name_fr": "INJECTION D'ACÉTATE DE SODIUM USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H2201",
      "number_of_ais": "1",
      "ai_group_no": "0113986001"
    },
    "created_date": "2024-12-10T22:03:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02181746",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2025-02-10T00:00:00-05:00",
    "actual_start_date": "2024-12-01T00:00:00-05:00",
    "actual_end_date": "2025-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-17T12:47:09-05:00",
    "status": "resolved",
    "en_comments": "The product is on allocation.",
    "fr_comments": "Le produit est soumis à une allocation.",
    "en_drug_brand_name": "SODIUM ACETATE INJECTION USP",
    "en_drug_common_name": "SODIUM ACETATE INJECTION",
    "fr_drug_brand_name": "SODIUM ACETATE INJECTION",
    "fr_drug_common_name": "INJECTION D'ACETATE DE SODIUM",
    "en_ingredients": "SODIUM ACETATE",
    "fr_ingredients": "Acétate de sodium",
    "drug_strength": "328MG",
    "drug_dosage_form": "SOLUTION\r\nLIQUID",
    "drug_dosage_form_fr": "Solution\r\nLiquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245357,
    "drug": {
      "current_status": "MARKETED",
      "id": 59761,
      "drug_code": 97182,
      "updated_date": "2025-12-03T00:34:01-05:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8263623,
          "ingredient": {
            "id": 16027,
            "ingredient_code": 22993,
            "en_name": "ELAGOLIX",
            "fr_name": "élagolix (Sodium de élagolix)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02481332",
      "brand_name": "ORILISSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0160710001"
    },
    "created_date": "2024-12-11T14:17:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481332",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "G03XA",
    "anticipated_start_date": "2024-12-16T00:00:00-05:00",
    "estimated_end_date": "2025-01-25T00:00:00-05:00",
    "actual_start_date": "2025-01-01T00:00:00-05:00",
    "actual_end_date": "2025-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-23T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Manufacturing delays",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "ORILISSA",
    "en_drug_common_name": "Orilissa",
    "fr_drug_brand_name": "Orilissa",
    "fr_drug_common_name": "Orilissa",
    "en_ingredients": "ELAGOLIX",
    "fr_ingredients": "élagolix (Sodium de élagolix)",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 blisters x 7 tablets in a carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245384,
    "drug": {
      "current_status": "MARKETED",
      "id": 100773,
      "drug_code": 99162,
      "updated_date": "2020-08-04T23:50:47-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265391,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02502038",
      "brand_name": "M-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2024-12-11T15:15:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502038",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2024-11-18T00:00:00-05:00",
    "estimated_end_date": "2025-04-20T00:00:00-04:00",
    "actual_end_date": "2025-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-01T15:01:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-AZITHROMYCIN",
    "en_drug_common_name": "M-AZITHROMYCIN",
    "fr_drug_brand_name": "M-AZITHROMYCIN",
    "fr_drug_common_name": "M-AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245387,
    "drug": {
      "current_status": "MARKETED",
      "id": 100773,
      "drug_code": 99162,
      "updated_date": "2020-08-04T23:50:47-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265391,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02502038",
      "brand_name": "M-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2024-12-11T15:19:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502038",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-08-19T00:00:00-04:00",
    "actual_end_date": "2025-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-01-27T14:57:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-AZITHROMYCIN",
    "en_drug_common_name": "M-AZITHROMYCIN",
    "fr_drug_brand_name": "M-AZITHROMYCIN",
    "fr_drug_common_name": "M-AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245390,
    "drug": {
      "current_status": "MARKETED",
      "id": 102178,
      "drug_code": 100892,
      "updated_date": "2021-09-09T05:14:11-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266551,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02519682",
      "brand_name": "M-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555002"
    },
    "created_date": "2024-12-11T15:22:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519682",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-02-10T14:29:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-BETAHISTINE",
    "en_drug_common_name": "M-BETAHISTINE",
    "fr_drug_brand_name": "M-BETAHISTINE",
    "fr_drug_common_name": "M-BETAHISTINE",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245393,
    "drug": {
      "current_status": "MARKETED",
      "id": 102179,
      "drug_code": 100893,
      "updated_date": "2021-09-09T05:14:11-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266552,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02519690",
      "brand_name": "M-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555003"
    },
    "created_date": "2024-12-11T15:25:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519690",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-02-10T14:28:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-BETAHISTINE",
    "en_drug_common_name": "M-BETAHISTINE",
    "fr_drug_brand_name": "M-BETAHISTINE",
    "fr_drug_common_name": "M-BETAHISTINE",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245396,
    "drug": {
      "current_status": "MARKETED",
      "id": 102180,
      "drug_code": 100894,
      "updated_date": "2021-09-09T05:14:11-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266553,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02519704",
      "brand_name": "M-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2024-12-11T15:26:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519704",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-09T00:00:00-05:00",
    "actual_end_date": "2025-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-02-10T14:28:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-BETAHISTINE",
    "en_drug_common_name": "M-BETAHISTINE",
    "fr_drug_brand_name": "M-BETAHISTINE",
    "fr_drug_common_name": "M-BETAHISTINE",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245399,
    "drug": {
      "current_status": "DORMANT",
      "id": 66484,
      "drug_code": 97988,
      "updated_date": "2025-12-03T02:32:47-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369654,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489805",
      "brand_name": "M-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2024-12-11T15:29:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489805",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2024-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-10-01T13:52:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "M-LANSOPRAZOLE",
    "en_drug_common_name": "M-LANSOPRAZOLE",
    "fr_drug_brand_name": "M-LANSOPRAZOLE",
    "fr_drug_common_name": "M-LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245402,
    "drug": {
      "current_status": "DORMANT",
      "id": 66486,
      "drug_code": 97989,
      "updated_date": "2025-12-03T02:32:47-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369655,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489813",
      "brand_name": "M-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2024-12-11T15:31:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489813",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2024-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-10-01T13:51:32-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "M-LANSOPRAZOLE",
    "en_drug_common_name": "M-LANSOPRAZOLE",
    "fr_drug_brand_name": "M-LANSOPRAZOLE",
    "fr_drug_common_name": "M-LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245405,
    "drug": {
      "current_status": "MARKETED",
      "id": 101685,
      "drug_code": 100250,
      "updated_date": "2021-04-08T05:03:50-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266144,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02513285",
      "brand_name": "M-LATANOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132916001"
    },
    "created_date": "2024-12-11T15:34:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02513285",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-03-03T13:57:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-LATANOPROST",
    "en_drug_common_name": "M-LATANOPROST",
    "fr_drug_brand_name": "M-LATANOPROST",
    "fr_drug_common_name": "M-LATANOPROST",
    "en_ingredients": "LATANOPROST",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "2.5 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245408,
    "drug": {
      "current_status": "MARKETED",
      "id": 101785,
      "drug_code": 100369,
      "updated_date": "2021-05-07T05:13:46-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266229,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8266228,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02514516",
      "brand_name": "M-LATANOPROST-TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248501001"
    },
    "created_date": "2024-12-11T15:39:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02514516",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-03-03T13:59:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-LATANOPROST-TIMOLOL",
    "en_drug_common_name": "M-LATANOPROST-TIMOLOL",
    "fr_drug_brand_name": "M-LATANOPROST-TIMOLOL",
    "fr_drug_common_name": "M-LATANOPROST-TIMOLOL",
    "en_ingredients": "TIMOLOL\r\nLATANOPROST",
    "fr_ingredients": "Timolol (Maléate de timolol)\r\nLatanoprost",
    "drug_strength": "5MG\r\n50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "2.5 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245411,
    "drug": {
      "current_status": "MARKETED",
      "id": 66472,
      "drug_code": 97829,
      "updated_date": "2025-05-15T02:37:47-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264086,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02488183",
      "brand_name": "M-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2024-12-11T15:42:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02488183",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2024-12-20T00:00:00-05:00",
    "actual_start_date": "2024-09-16T00:00:00-04:00",
    "actual_end_date": "2020-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T13:43:06-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "M-MONTELUKAST",
    "en_drug_common_name": "M-MONTELUKAST",
    "fr_drug_brand_name": "M-MONTELUKAST",
    "fr_drug_common_name": "M-MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "Montélukast (Montélukast sodique)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245420,
    "drug": {
      "current_status": "MARKETED",
      "id": 62823,
      "drug_code": 97183,
      "updated_date": "2025-12-03T00:34:01-05:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8263624,
          "ingredient": {
            "id": 16027,
            "ingredient_code": 22993,
            "en_name": "ELAGOLIX",
            "fr_name": "élagolix (Sodium de élagolix)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02481340",
      "brand_name": "ORILISSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0160710002"
    },
    "created_date": "2024-12-11T16:57:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481340",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "H01CC",
    "anticipated_start_date": "2025-01-20T00:00:00-05:00",
    "estimated_end_date": "2025-03-24T00:00:00-04:00",
    "actual_start_date": "2025-01-16T00:00:00-05:00",
    "actual_end_date": "2025-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-03-15T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in manufacturing",
    "fr_comments": "Délai à la fabrication",
    "en_drug_brand_name": "ORILISSA",
    "en_drug_common_name": "Orilissa",
    "fr_drug_brand_name": "Orilissa",
    "fr_drug_common_name": "Orilissa",
    "en_ingredients": "ELAGOLIX",
    "fr_ingredients": "élagolix (Sodium de élagolix)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 blisters x 14 tablets  in a carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245442,
    "drug": {
      "current_status": "MARKETED",
      "id": 4534,
      "drug_code": 2215,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250390,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335088",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48168",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2024-12-11T20:54:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335088",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-11T20:54:53-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "ELAVIL",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245445,
    "drug": {
      "current_status": "MARKETED",
      "id": 2492,
      "drug_code": 15927,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252073,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02084090",
      "brand_name": "MINOCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77690",
      "number_of_ais": "1",
      "ai_group_no": "0131309001"
    },
    "created_date": "2024-12-11T20:55:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02084090",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "anticipated_start_date": "2024-12-10T00:00:00-05:00",
    "estimated_end_date": "2024-12-20T00:00:00-05:00",
    "actual_end_date": "2025-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-13T17:04:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINOCYCLINE",
    "en_drug_common_name": "Minocycline",
    "fr_drug_brand_name": "Minocycline",
    "fr_drug_common_name": "Minocycline",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "Minocycline (Chlorhydrate de minocycline)",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245448,
    "drug": {
      "current_status": "MARKETED",
      "id": 2248,
      "drug_code": 15,
      "updated_date": "2025-05-15T02:30:25-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250109,
          "ingredient": {
            "id": 1112,
            "ingredient_code": 11121,
            "en_name": "NORTRIPTYLINE",
            "fr_name": "Nortriptyline (Chlorhydrate de nortriptyline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00015229",
      "brand_name": "AVENTYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "00226",
      "number_of_ais": "1",
      "ai_group_no": "0102630002"
    },
    "created_date": "2024-12-11T20:57:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00015229",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2024-12-10T00:00:00-05:00",
    "estimated_end_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2024-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-19T14:51:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AVENTYL",
    "en_drug_common_name": "Aventyl",
    "fr_drug_brand_name": "Aventyl",
    "fr_drug_common_name": "Aventyl",
    "en_ingredients": "NORTRIPTYLINE",
    "fr_ingredients": "Nortriptyline (Chlorhydrate de nortriptyline)",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245452,
    "drug": {
      "current_status": "MARKETED",
      "id": 103892,
      "drug_code": 102595,
      "updated_date": "2024-04-10T04:38:02-04:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8268034,
          "ingredient": {
            "id": 36125,
            "ingredient_code": 23833,
            "en_name": "NIRSEVIMAB",
            "fr_name": "Nirsévimab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02537214",
      "brand_name": "BEYFORTUS",
      "brand_name_fr": "BEYFORTUS",
      "descriptor": "SINGLE-USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0164561001"
    },
    "created_date": "2024-12-11T21:20:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02537214",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "J06BD",
    "anticipated_start_date": "2024-12-20T00:00:00-05:00",
    "estimated_end_date": "2025-03-30T00:00:00-04:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-04-08T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Sanofi is proactively securing additional doses from our global supply to quickly respond to an  increase in demand, following inquiries for more doses to address a predicted surge in provincial uptake as the RSV season is projected to peak in January.  The additional volumes are pre-emptive in nature and beyond the provincial contractual commitments.",
    "fr_comments": "Sanofi sécurise de manière proactive des doses supplémentaires à partir de son stock mondial afin de répondre rapidement à une augmentation de la demande, suite à des demandes de doses supplémentaires pour faire face à une augmentation prévue de l'utilisation provinciale, alors que la saison du VRS devrait atteindre son pic en janvier.  Les volumes supplémentaires sont de nature préventive et vont au-delà des engagements contractuels provinciaux.",
    "en_drug_brand_name": "BEYFORTUS",
    "en_drug_common_name": "Beyfortus",
    "fr_drug_brand_name": "BEYFORTUS® 100 mg",
    "fr_drug_common_name": "Beyfortus",
    "en_ingredients": "NIRSEVIMAB",
    "fr_ingredients": "Nirsévimab",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "100 mg single-use, pre-filled syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245456,
    "drug": {
      "current_status": "MARKETED",
      "id": 4134,
      "drug_code": 19962,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252587,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216353",
      "brand_name": "APO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82261",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2024-12-11T22:09:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216353",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2025-02-19T00:00:00-05:00",
    "actual_end_date": "2025-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-14T20:29:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "APO-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxétine (Chlorhydrate de fluoxétine)",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245459,
    "drug": {
      "current_status": "MARKETED",
      "id": 4132,
      "drug_code": 19961,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252586,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216361",
      "brand_name": "APO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82260",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2024-12-11T22:10:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216361",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2025-01-28T00:00:00-05:00",
    "actual_end_date": "2025-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-14T20:29:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "APO-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxétine (Chlorhydrate de fluoxétine)",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245462,
    "drug": {
      "current_status": "MARKETED",
      "id": 4132,
      "drug_code": 19961,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252586,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216361",
      "brand_name": "APO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82260",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2024-12-11T22:10:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216361",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2025-07-31T00:00:00-04:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-10T19:52:15-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "APO-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxétine (Chlorhydrate de fluoxétine)",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245476,
    "drug": {
      "current_status": "MARKETED",
      "id": 28686,
      "drug_code": 90815,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260409,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02423421",
      "brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521008"
    },
    "created_date": "2024-12-12T13:37:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423421",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2025-01-15T00:00:00-05:00",
    "estimated_end_date": "2025-01-28T00:00:00-05:00",
    "actual_end_date": "2025-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-28T14:46:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "9.5MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "30 Patches",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245485,
    "drug": {
      "current_status": "MARKETED",
      "id": 5450,
      "drug_code": 36179,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252842,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252841,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "730",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252840,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "11200",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02200104",
      "brand_name": "CREON MINIMICROSPHERES 10",
      "brand_name_fr": "CREON MINIMICROSPHERES 10",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3491",
      "number_of_ais": "3",
      "ai_group_no": "0302964040"
    },
    "created_date": "2024-12-12T13:42:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02200104",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2024-11-22T00:00:00-05:00",
    "actual_end_date": "2024-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-12-16T16:46:29-05:00",
    "status": "resolved",
    "en_comments": "Globally Allocated SKU",
    "fr_comments": "Globally Allocated SKU",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 10",
    "en_drug_common_name": "AMYLASE LIPASE PROTEASE",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 10",
    "fr_drug_common_name": "Amylase Lipase Protéase",
    "en_ingredients": "AMYLASE\r\nLIPASE\r\nPROTEASE",
    "fr_ingredients": "Amylase\r\nLipase\r\nProtéase",
    "drug_strength": "11200UNIT\r\n10000UNIT\r\n730UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245496,
    "drug": {
      "current_status": "MARKETED",
      "id": 102683,
      "drug_code": 101278,
      "updated_date": "2022-02-08T06:12:38-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8266859,
          "ingredient": {
            "id": 3870,
            "ingredient_code": 22124,
            "en_name": "GUANFACINE",
            "fr_name": "Guanfacine (Chlorhydrate de guanfacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02523728",
      "brand_name": "APO-GUANFACINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154470001"
    },
    "created_date": "2024-12-12T14:42:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02523728",
    "company_name": "APOTEX INC",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-17T21:40:03-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-GUANFACINE XR",
    "en_drug_common_name": "GUANFACINE XR",
    "fr_drug_brand_name": "APO-GUANFACINE XR",
    "fr_drug_common_name": "GUANFACINE XR",
    "en_ingredients": "GUANFACINE",
    "fr_ingredients": "Guanfacine (Chlorhydrate de guanfacine)",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245499,
    "drug": {
      "current_status": "MARKETED",
      "id": 102686,
      "drug_code": 101280,
      "updated_date": "2022-02-08T06:12:45-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8266861,
          "ingredient": {
            "id": 3870,
            "ingredient_code": 22124,
            "en_name": "GUANFACINE",
            "fr_name": "Guanfacine (Chlorhydrate de guanfacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02523744",
      "brand_name": "APO-GUANFACINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154470003"
    },
    "created_date": "2024-12-12T14:42:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02523744",
    "company_name": "APOTEX INC",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-17T21:40:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GUANFACINE XR",
    "en_drug_common_name": "GUANFACINE XR",
    "fr_drug_brand_name": "APO-GUANFACINE XR",
    "fr_drug_common_name": "GUANFACINE XR",
    "en_ingredients": "GUANFACINE",
    "fr_ingredients": "Guanfacine (Chlorhydrate de guanfacine)",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245502,
    "drug": {
      "current_status": "MARKETED",
      "id": 104235,
      "drug_code": 102995,
      "updated_date": "2023-10-26T01:12:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8268425,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02541300",
      "brand_name": "APO-CANDESARTAN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2024-12-12T14:44:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02541300",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-03-07T00:00:00-05:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-07T15:59:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CANDESARTAN TABLETS",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "APO-CANDESARTAN TABLETS",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245505,
    "drug": {
      "current_status": "MARKETED",
      "id": 17030,
      "drug_code": 78058,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256006,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295261",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2024-12-12T14:45:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295261",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T18:14:33-05:00",
    "status": "resolved",
    "en_comments": "500 BTL available",
    "fr_comments": "500 btl disponible",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine (Atorvastatine calcique)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245508,
    "drug": {
      "current_status": "MARKETED",
      "id": 17156,
      "drug_code": 78185,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256055,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02296527",
      "brand_name": "APO-LATANOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132916002"
    },
    "created_date": "2024-12-12T14:46:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296527",
    "company_name": "APOTEX INC",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-27T20:43:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LATANOPROST",
    "en_drug_common_name": "LATANOPROST",
    "fr_drug_brand_name": "APO-LATANOPROST",
    "fr_drug_common_name": "LATANOPROST",
    "en_ingredients": "LATANOPROST",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245511,
    "drug": {
      "current_status": "MARKETED",
      "id": 25426,
      "drug_code": 87869,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259212,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393476",
      "brand_name": "APO-RIZATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2024-12-12T14:47:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393476",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-24T16:03:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIZATRIPTAN",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "APO-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan (Benzoate de rizatriptan)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245516,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20406,
      "drug_code": 81955,
      "updated_date": "2025-12-03T01:27:00-05:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8347680,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8347679,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02333864",
      "brand_name": "JANUMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252656002"
    },
    "created_date": "2024-12-12T15:35:24-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02333864",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2025-08-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-08-14T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JANUMET",
    "en_drug_common_name": "sitagliptin and metformin hydrochloride tablets",
    "fr_drug_brand_name": "JANUMET",
    "fr_drug_common_name": "comprimés de sitagliptine et de chlorhydrate de metformine",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nSITAGLIPTIN",
    "fr_ingredients": "Chlorhydrate de metformine\r\nSitagliptine (Malate de sitagliptine)",
    "drug_strength": "850MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60TAB",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245519,
    "drug": {
      "current_status": "MARKETED",
      "id": 99373,
      "drug_code": 96361,
      "updated_date": "2020-04-03T06:53:39-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8263142,
          "ingredient": {
            "id": 1094,
            "ingredient_code": 9967,
            "en_name": "GLYCOPYRROLATE",
            "fr_name": "Glycopyrrolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02473895",
      "brand_name": "GLYCOPYRROLATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "2 ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102396002"
    },
    "created_date": "2024-12-12T15:41:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473895",
    "company_name": "STERIMAX INC",
    "atc_number": "A03AB",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2025-09-15T00:00:00-04:00",
    "actual_start_date": "2024-12-10T00:00:00-05:00",
    "actual_end_date": "2025-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-09-18T13:46:30-04:00",
    "status": "resolved",
    "en_comments": "Contract coverage is in place.",
    "fr_comments": "Couverture de contrat est en place.",
    "en_drug_brand_name": "GLYCOPYRROLATE INJECTION USP",
    "en_drug_common_name": "GLYCOPYRROLATE INJECTION USP",
    "fr_drug_brand_name": "GLYCOPYRROLATE INJECTION USP",
    "fr_drug_common_name": "GLYCOPYRROLATE INJECTION USP",
    "en_ingredients": "GLYCOPYRROLATE",
    "fr_ingredients": "Glycopyrrolate",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 VIALS X 2 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245595,
    "drug": {
      "current_status": "MARKETED",
      "id": 1716,
      "drug_code": 13690,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251801,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01927914",
      "brand_name": "TEVA-TOPILENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75127",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2024-12-13T14:39:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01927914",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "actual_end_date": "2025-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-06T18:22:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPILENE",
    "en_drug_common_name": "TOPILENE 0.05% LOTION",
    "fr_drug_brand_name": "TEVA-TOPILENE 0.05% LOTION",
    "fr_drug_common_name": "TOPILENE 0.05% LOTION",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone (Dipropionate de bétaméthasone)",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245598,
    "drug": {
      "current_status": "MARKETED",
      "id": 3216,
      "drug_code": 18209,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252274,
          "ingredient": {
            "id": 1376,
            "ingredient_code": 11389,
            "en_name": "LEUCOVORIN",
            "fr_name": "Leucovorine (Leucovorine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02087316",
      "brand_name": "LEUCOVORIN CALCIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80432",
      "number_of_ais": "1",
      "ai_group_no": "0108436002"
    },
    "created_date": "2024-12-13T14:40:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02087316",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2025-03-01T00:00:00-05:00",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "actual_end_date": "2025-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-28T15:41:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEUCOVORIN CALCIUM INJECTION",
    "en_drug_common_name": "LEUCOVORIN CALCIUM INJ 10MG/ML",
    "fr_drug_brand_name": "LEUCOVORIN CALCIUM INJ 10MG/ML",
    "fr_drug_common_name": "LEUCOVORIN CALCIUM INJ 10MG/ML",
    "en_ingredients": "LEUCOVORIN",
    "fr_ingredients": "Leucovorine (Leucovorine calcique)",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "50ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245601,
    "drug": {
      "current_status": "MARKETED",
      "id": 3906,
      "drug_code": 19524,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252505,
          "ingredient": {
            "id": 1086,
            "ingredient_code": 14088,
            "en_name": "MESALAZINE",
            "fr_name": "Mésalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02171929",
      "brand_name": "TEVA-5 ASA",
      "brand_name_fr": "",
      "descriptor": "ALSO KNOWN AS MESALAMINE",
      "pediatric_flag": false,
      "accession_number": "81821",
      "number_of_ais": "1",
      "ai_group_no": "0116808001"
    },
    "created_date": "2024-12-13T14:41:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02171929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_start_date": "2024-12-12T00:00:00-05:00",
    "actual_end_date": "2025-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-13T20:24:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-5 ASA",
    "en_drug_common_name": "ASA 400MG TABLETS",
    "fr_drug_brand_name": "TEVA-5 ASA 400MG TABLETS",
    "fr_drug_common_name": "ASA 400MG TABLETS",
    "en_ingredients": "MESALAZINE",
    "fr_ingredients": "Mésalazine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245606,
    "drug": {
      "current_status": "MARKETED",
      "id": 12524,
      "drug_code": 71241,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254600,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247008",
      "brand_name": "TEVA-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2024-12-13T14:45:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247008",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "actual_end_date": "2025-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-20T19:21:23-04:00",
    "status": "resolved",
    "en_comments": "02247008",
    "en_drug_brand_name": "TEVA-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN 10MG TABS",
    "fr_drug_brand_name": "TEVA-PRAVASTATIN 10MG TABS",
    "fr_drug_common_name": "PRAVASTATIN 10MG TABS",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245609,
    "drug": {
      "current_status": "MARKETED",
      "id": 25346,
      "drug_code": 87819,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259188,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392925",
      "brand_name": "TEVA-NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009003"
    },
    "created_date": "2024-12-13T14:46:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392925",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2025-01-20T00:00:00-05:00",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "actual_end_date": "2025-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-23T16:50:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NABILONE",
    "en_drug_common_name": "TEVA-NABILONE 0.25MG CAPS",
    "fr_drug_brand_name": "TEVA-NABILONE 0.25MG CAPS",
    "fr_drug_common_name": "NABILONE 0.25MG CAPS",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245612,
    "drug": {
      "current_status": "MARKETED",
      "id": 25644,
      "drug_code": 88053,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259262,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395444",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-12-13T14:50:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-28T16:37:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR 50MG TAB",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR 50MG TAB",
    "fr_drug_common_name": "QUETIAPINE XR 50MG TAB",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245615,
    "drug": {
      "current_status": "MARKETED",
      "id": 27444,
      "drug_code": 89677,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259929,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412209",
      "brand_name": "TEVA-TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2024-12-13T14:54:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412209",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2026-03-31T00:00:00-04:00",
    "actual_start_date": "2024-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-30T16:40:30-04:00",
    "status": "active_confirmed",
    "en_comments": "Item is on Suspended Supply",
    "en_drug_brand_name": "TEVA-TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE 4MG ER CAPS",
    "fr_drug_brand_name": "TEVA-TOLTERODINE 4MG ER CAPS",
    "fr_drug_common_name": "TOLTERODINE 4MG ER CAPS",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's & 100's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245630,
    "drug": {
      "current_status": "MARKETED",
      "id": 8696,
      "drug_code": 60565,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253507,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02237245",
      "brand_name": "FLOVENT DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685007"
    },
    "created_date": "2024-12-13T17:59:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237245",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2024-12-12T00:00:00-05:00",
    "actual_end_date": "2025-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLOVENT DISKUS",
    "en_drug_common_name": "fluticasone propionate powder for inhalation",
    "fr_drug_brand_name": "FLOVENT DISKUS",
    "fr_drug_common_name": "propionate de fluticasone en poudre pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245633,
    "drug": {
      "current_status": "MARKETED",
      "id": 3964,
      "drug_code": 19615,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 144,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 14255,
        "mfr_code": "",
        "name": "VIIV HEALTHCARE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "1400",
        "street_name": "75 RUE QUEEN",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3C 2N6",
        "post_office_box": "",
        "contact_information": "1-877-393-8448"
      },
      "drug_ingredients": [
        {
          "id": 8252539,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02192691",
      "brand_name": "3TC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81912",
      "number_of_ais": "1",
      "ai_group_no": "0128157002"
    },
    "created_date": "2024-12-13T18:33:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02192691",
    "company_name": "VIIV HEALTHCARE ULC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2025-02-19T00:00:00-05:00",
    "actual_start_date": "2024-12-12T00:00:00-05:00",
    "actual_end_date": "2025-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-22T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "3TC",
    "en_drug_common_name": "lamivudine oral solution",
    "fr_drug_brand_name": "3TC",
    "fr_drug_common_name": "solution buvable de lamivudine",
    "en_ingredients": "LAMIVUDINE",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "240 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245665,
    "drug": {
      "current_status": "MARKETED",
      "id": 25082,
      "drug_code": 87588,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259092,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02390442",
      "brand_name": "TARO-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752003"
    },
    "created_date": "2024-12-13T20:29:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390442",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-04T00:00:00-05:00",
    "actual_end_date": "2024-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-27T20:29:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "TARO-CLARITHROMYCIN",
    "fr_drug_common_name": "Clarithromycin",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION\r\nGRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension\r\nGranules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "55 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245670,
    "drug": {
      "current_status": "MARKETED",
      "id": 14684,
      "drug_code": 74976,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255280,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264315",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596004"
    },
    "created_date": "2024-12-13T21:49:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264315",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2024-12-18T00:00:00-05:00",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_end_date": "2025-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-11T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that we will be encountering a supply interruption on our Heparin Sodium Injection, USP 1,000 USP units/mL MD Vial 30 mL effective December 18, 2024, until January 17, 2025.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer que notre présentation d’Héparine sodique injectable, USP 1 000 unités USP/mL, fiole DM, 30 mL sera en situation d’interruption d’approvisionnement du 18 décembre 2024 au 17 janvier 2025.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "1000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "30 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245686,
    "drug": {
      "current_status": "MARKETED",
      "id": 57787,
      "drug_code": 95718,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262775,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468700",
      "brand_name": "SANDOZ PRAVASTATIN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2024-12-16T14:28:41-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02468700",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2024-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-17T06:00:27-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "en_drug_common_name": "PRAVASTATIN SDZ",
    "fr_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "fr_drug_common_name": "PRAVASTATIN SDZ",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245725,
    "drug": {
      "current_status": "MARKETED",
      "id": 762,
      "drug_code": 11752,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251565,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919342",
      "brand_name": "LUVOX",
      "brand_name_fr": "LUVOX",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72652",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2024-12-16T16:51:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919342",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2025-01-09T00:00:00-05:00",
    "actual_start_date": "2025-01-15T00:00:00-05:00",
    "actual_end_date": "2025-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-28T14:58:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LUVOX",
    "en_drug_common_name": "FLUVOXAMINE MALEATE",
    "fr_drug_brand_name": "LUVOX",
    "fr_drug_common_name": "FLUVOXAMINE MALEATE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x15BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245741,
    "drug": {
      "current_status": "MARKETED",
      "id": 24784,
      "drug_code": 87338,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258949,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387808",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2024-12-16T17:49:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387808",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-12-13T00:00:00-05:00",
    "actual_end_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245744,
    "drug": {
      "current_status": "MARKETED",
      "id": 24788,
      "drug_code": 87340,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258951,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387824",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-12-16T17:51:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387824",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-12-13T00:00:00-05:00",
    "actual_end_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245747,
    "drug": {
      "current_status": "MARKETED",
      "id": 24790,
      "drug_code": 87341,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258952,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387832",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-12-16T17:52:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387832",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-12-13T00:00:00-05:00",
    "actual_end_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245750,
    "drug": {
      "current_status": "MARKETED",
      "id": 98780,
      "drug_code": 93703,
      "updated_date": "2020-04-03T06:53:03-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261691,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02450909",
      "brand_name": "ACH-QUETIAPINE FUMARATE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2024-12-16T17:53:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450909",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-12-16T17:55:04-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-QUETIAPINE FUMARATE XR",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "ACH Quétiapine Fumarate XR",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245769,
    "drug": {
      "current_status": "MARKETED",
      "id": 7116,
      "drug_code": 48191,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253238,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253237,
          "ingredient": {
            "id": 930,
            "ingredient_code": 1859,
            "en_name": "MISOPROSTOL",
            "fr_name": "Misoprostol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229837",
      "brand_name": "ARTHROTEC 75",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222885002"
    },
    "created_date": "2024-12-16T18:09:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229837",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "actual_start_date": "2025-03-27T00:00:00-04:00",
    "actual_end_date": "2025-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-17T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ARTHROTEC 75",
    "en_drug_common_name": "ARTHROTEC 75",
    "fr_drug_brand_name": "ARTHROTEC 75",
    "fr_drug_common_name": "ARTHROTEC 75",
    "en_ingredients": "MISOPROSTOL\r\nDICLOFENAC SODIUM",
    "fr_ingredients": "Misoprostol\r\nDiclofénac sodique",
    "drug_strength": "200MCG\r\n75MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245804,
    "drug": {
      "current_status": "MARKETED",
      "id": 100441,
      "drug_code": 98805,
      "updated_date": "2020-06-16T22:21:14-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8265008,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02498278",
      "brand_name": "MORPHINE SULFATE INJECTION EPIDURAL",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545007"
    },
    "created_date": "2024-12-16T19:04:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02498278",
    "company_name": "STERIMAX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2024-12-30T00:00:00-05:00",
    "estimated_end_date": "2025-03-04T00:00:00-05:00",
    "actual_end_date": "2025-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-22T06:00:15-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory is available at McKesson.  Contract coverage is in place as needed.",
    "fr_comments": "Inventaire est disponible chez McKesson en quantité limitée.  Couverture de contrat est en place.",
    "en_drug_brand_name": "MORPHINE SULFATE INJECTION EPIDURAL",
    "en_drug_common_name": "MORPHINE SULFATE INJECTION EPIDURAL",
    "fr_drug_brand_name": "SULFATE DE MORPHINE INJECTION ÉPIDURALE",
    "fr_drug_common_name": "SULFATE DE MORPHINE INJECTION ÉPIDURALE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL",
    "drug_route_fr": "Épidurale",
    "drug_package_quantity": "10 VIALS X 10 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245810,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2024-12-16T20:15:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2024-12-16T00:00:00-05:00",
    "estimated_end_date": "2025-01-13T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Hydromorphone hydrochloride",
    "fr_drug_brand_name": "DILAUDID",
    "fr_drug_common_name": "chlorhydrate d’Hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245813,
    "drug": {
      "current_status": "MARKETED",
      "id": 100295,
      "drug_code": 98660,
      "updated_date": "2024-05-09T01:50:20-04:00",
      "company": {
        "id": 17330,
        "created_date": "2024-05-09T01:45:09-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 19068,
        "mfr_code": "",
        "name": "VANTIVE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6675 MILLCREEK DRIVE, UNIT 2",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264853,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.03",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8264852,
          "ingredient": {
            "id": 156,
            "ingredient_code": 10290,
            "en_name": "SODIUM CITRATE",
            "fr_name": "Citrate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.29",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        }
      ],
      "din": "02496755",
      "brand_name": "REGIOCIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0262055001"
    },
    "created_date": "2024-12-16T20:17:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496755",
    "company_name": "VANTIVE ULC",
    "atc_number": "B05ZB",
    "atc_description": "HEMODIALYTICS AND HEMOFILTRATES",
    "anticipated_start_date": "2024-12-16T00:00:00-05:00",
    "estimated_end_date": "2025-04-30T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-01T17:08:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "REGIOCIT",
    "en_drug_common_name": "Sodium chloride and sodium citrate solution",
    "fr_drug_brand_name": "REGIOCIT",
    "fr_drug_common_name": "Solution de chlorure de sodium et de citrate de sodium",
    "en_ingredients": "SODIUM CITRATE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Citrate de sodium\r\nChlorure de sodium",
    "drug_strength": "5.29G\r\n5.03G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EXTRACORPOREAL",
    "drug_route_fr": "Extracorporelle",
    "drug_package_quantity": "5000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245818,
    "drug": {
      "current_status": "MARKETED",
      "id": 6730,
      "drug_code": 44188,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253162,
          "ingredient": {
            "id": 2236,
            "ingredient_code": 420,
            "en_name": "GADODIAMIDE",
            "fr_name": "Gadodiamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "287",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172771",
      "brand_name": "OMNISCAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9823",
      "number_of_ais": "1",
      "ai_group_no": "0126095001"
    },
    "created_date": "2024-12-16T20:39:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172771",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "estimated_end_date": "2025-01-03T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T06:00:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNISCAN",
    "en_drug_common_name": "gadodiamide injection USP",
    "fr_drug_brand_name": "Omniscan",
    "fr_drug_common_name": "gadodiamide pour injection USP",
    "en_ingredients": "GADODIAMIDE",
    "fr_ingredients": "Gadodiamide",
    "drug_strength": "287MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245839,
    "drug": {
      "current_status": "MARKETED",
      "id": 12500,
      "drug_code": 71196,
      "updated_date": "2025-12-03T00:30:52-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254597,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02246967",
      "brand_name": "SANDOZ ESTRADIOL DERM 50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457035"
    },
    "created_date": "2024-12-16T21:43:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246967",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2025-03-07T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-03-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-03-11T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESTRADIOL DERM 50",
    "en_drug_common_name": "ESTRADIOL DERM 50",
    "fr_drug_brand_name": "SANDOZ ESTRADIOL DERM 50",
    "fr_drug_common_name": "ESTRADIOL DERM 50",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245843,
    "drug": {
      "current_status": "MARKETED",
      "id": 20056,
      "drug_code": 81399,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257058,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328461",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2024-12-16T21:45:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328461",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-01-24T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-01-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-28T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245847,
    "drug": {
      "current_status": "MARKETED",
      "id": 23800,
      "drug_code": 86467,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258577,
          "ingredient": {
            "id": 2158,
            "ingredient_code": 41,
            "en_name": "MEROPENEM",
            "fr_name": "Méropénem (Méropénem Trihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378795",
      "brand_name": "MEROPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128599003"
    },
    "created_date": "2024-12-16T21:46:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378795",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:41:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MEROPENEM FOR INJECTION",
    "en_drug_common_name": "MEROPENEM FOR INJECTION",
    "fr_drug_brand_name": "MEROPENEM FOR INJECTION",
    "fr_drug_common_name": "MEROPENEM FOR INJECTION",
    "en_ingredients": "MEROPENEM",
    "fr_ingredients": "Méropénem (Méropénem Trihydraté)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10PSOIJ",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245851,
    "drug": {
      "current_status": "MARKETED",
      "id": 28334,
      "drug_code": 90478,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260273,
          "ingredient": {
            "id": 2466,
            "ingredient_code": 11561,
            "en_name": "OLOPATADINE",
            "fr_name": "Olopatadine (Chlorhydrate d'olopatadine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02420171",
      "brand_name": "SANDOZ OLOPATADINE 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132394002"
    },
    "created_date": "2024-12-16T21:49:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420171",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-16T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:43:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLOPATADINE 0.2%",
    "en_drug_common_name": "OLOPATADINE 0.2%",
    "fr_drug_brand_name": "SANDOZ OLOPATADINE 0.2%",
    "fr_drug_common_name": "OLOPATADINE 0.2%",
    "en_ingredients": "OLOPATADINE",
    "fr_ingredients": "Olopatadine (Chlorhydrate d'olopatadine)",
    "drug_strength": "0.2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245896,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2024-12-17T18:38:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2024-12-17T00:00:00-05:00",
    "estimated_end_date": "2025-02-14T00:00:00-05:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-13T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT PRESERVATIVE-FREE",
    "en_drug_common_name": "Dorzolamide and Timolol Ophthalmic Solution",
    "fr_drug_brand_name": "COSOPT",
    "fr_drug_common_name": "Collyre de dorzolamide et de timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "Timolol (Maléate de timolol)\r\nDorzolamide (Chlorhydrate de dorzolamide)",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245899,
    "drug": {
      "current_status": "MARKETED",
      "id": 21758,
      "drug_code": 84157,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8257763,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356422",
      "brand_name": "DIAMICRON MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE BREAKABLE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2024-12-17T20:11:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356422",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-14T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DIAMICRON MR",
    "en_drug_common_name": "Gliclazide modified release tablets",
    "fr_drug_brand_name": "Diamicron",
    "fr_drug_common_name": "Gliclazide modified release tablets",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245958,
    "drug": {
      "current_status": "MARKETED",
      "id": 24096,
      "drug_code": 86721,
      "updated_date": "2025-12-03T00:31:55-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258673,
          "ingredient": {
            "id": 3782,
            "ingredient_code": 21230,
            "en_name": "AZILSARTAN MEDOXOMIL",
            "fr_name": "Azilsartan Médoxomil (Azilsartan Médoxomil Potassium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381389",
      "brand_name": "EDARBI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153128001"
    },
    "created_date": "2024-12-18T18:49:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381389",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2025-01-09T00:00:00-05:00",
    "estimated_end_date": "2025-01-16T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-15T20:45:18-05:00",
    "status": "resolved",
    "en_comments": "Missing/ Waiting on Documents from Supplier",
    "fr_comments": "Missing/ Waiting on Documents from Supplier",
    "en_drug_brand_name": "EDARBI",
    "en_drug_common_name": "EDARBI",
    "fr_drug_brand_name": "EDARBI",
    "fr_drug_common_name": "EDARBI",
    "en_ingredients": "AZILSARTAN MEDOXOMIL",
    "fr_ingredients": "Azilsartan Médoxomil (Azilsartan Médoxomil Potassium)",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28ct",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245961,
    "drug": {
      "current_status": "MARKETED",
      "id": 10430,
      "drug_code": 65671,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253938,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242001",
      "brand_name": "CARBOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "20ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583002"
    },
    "created_date": "2024-12-18T19:02:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242001",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOCAINE 2%",
    "en_drug_common_name": "CARBOCAINE 2%",
    "fr_drug_brand_name": "CARBOCAINE 2%",
    "fr_drug_common_name": "CARBOCAINE 2%",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINTRACAUDAL\r\nEPIDURAL\r\nINTRACAUDAL",
    "drug_route_fr": "Épidurale\r\nIntracaudale\r\nÉpidurale\r\nIntracaudale",
    "drug_package_quantity": "10 X 20ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245976,
    "drug": {
      "current_status": "MARKETED",
      "id": 21632,
      "drug_code": 84015,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257730,
          "ingredient": {
            "id": 3672,
            "ingredient_code": 20625,
            "en_name": "DEXLANSOPRAZOLE",
            "fr_name": "Dexlansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354969",
      "brand_name": "DEXILANT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152766002"
    },
    "created_date": "2024-12-19T13:55:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354969",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2024-12-19T00:00:00-05:00",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXILANT",
    "en_drug_common_name": "Dexlansoprazole delayed release capsules",
    "fr_drug_brand_name": "DEXILANT",
    "fr_drug_common_name": "Dexlansoprazole delayed release capsules",
    "en_ingredients": "DEXLANSOPRAZOLE",
    "fr_ingredients": "Dexlansoprazole",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nNASOGASTRIC\r\nORAL\r\nNASOGASTRIC",
    "drug_route_fr": "Orale\r\nNASOGASTRIQUE\r\nOrale\r\nNasogastrique",
    "drug_package_quantity": "Bottles of 90's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245991,
    "drug": {
      "current_status": "MARKETED",
      "id": 10604,
      "drug_code": 66190,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254017,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242465",
      "brand_name": "DESMOPRESSIN SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050001"
    },
    "created_date": "2024-12-19T15:05:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242465",
    "company_name": "AA PHARMA INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2024-12-24T00:00:00-05:00",
    "estimated_end_date": "2025-01-20T00:00:00-05:00",
    "actual_end_date": "2025-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-24T14:00:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DESMOPRESSIN SPRAY",
    "en_drug_common_name": "Desmopressin Spray",
    "fr_drug_brand_name": "Desmopressin Spray",
    "fr_drug_common_name": "Desmopressin Spray",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245994,
    "drug": {
      "current_status": "MARKETED",
      "id": 12052,
      "drug_code": 69999,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254469,
          "ingredient": {
            "id": 2978,
            "ingredient_code": 5863,
            "en_name": "METHAZOLAMIDE",
            "fr_name": "Méthazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245882",
      "brand_name": "METHAZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107657001"
    },
    "created_date": "2024-12-19T15:13:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245882",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2024-12-24T00:00:00-05:00",
    "estimated_end_date": "2025-06-04T00:00:00-04:00",
    "actual_end_date": "2025-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-29T12:19:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHAZOLAMIDE",
    "en_drug_common_name": "METHAZOLAMIDE",
    "fr_drug_brand_name": "METHAZOLAMIDE",
    "fr_drug_common_name": "METHAZOLAMIDE",
    "en_ingredients": "METHAZOLAMIDE",
    "fr_ingredients": "Méthazolamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 245997,
    "drug": {
      "current_status": "MARKETED",
      "id": 101851,
      "drug_code": 98324,
      "updated_date": "2023-10-26T00:04:16-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264523,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493268",
      "brand_name": "AA-RISEDRONATE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2024-12-19T15:17:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493268",
    "company_name": "AA PHARMA INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "anticipated_start_date": "2024-12-24T00:00:00-05:00",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_end_date": "2025-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-12T20:33:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AA-RISEDRONATE DR",
    "en_drug_common_name": "AA-RISEDRONATE DR",
    "fr_drug_brand_name": "AA-RISEDRONATE DR",
    "fr_drug_common_name": "AA-RISEDRONATE DR",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique (Hémipentahydrate de risédronate sodique)",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246001,
    "drug": {
      "current_status": "MARKETED",
      "id": 29608,
      "drug_code": 9164,
      "updated_date": "2025-05-15T02:30:43-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251121,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00721891",
      "brand_name": "EPINEPHRINE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68031",
      "number_of_ais": "1",
      "ai_group_no": "0104871002"
    },
    "created_date": "2024-12-19T15:50:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00721891",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "EPINEPHRINE INJECTION USP",
    "en_drug_common_name": "EPINEPHINE INJECTION USP",
    "fr_drug_brand_name": "EPINEPHRINE INJECTION USP",
    "fr_drug_common_name": "EPINEPHRINE INJECTION USP",
    "en_ingredients": "EPINEPHRINE",
    "fr_ingredients": "Épinéphrine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATRACHEAL\r\nINTRAMUSCULAR\r\nINTRACARDIAC\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATRACHEAL\r\nINTRAMUSCULAR\r\nINTRACARDIAC",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntratrachéale\r\nIntramusculaire\r\nIntracardiaque\r\nSous-cutanée\r\nIntraveineuse\r\nIntratrachéale\r\nIntramusculaire\r\nIntracardiaque",
    "drug_package_quantity": "10 X 1ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246051,
    "drug": {
      "current_status": "MARKETED",
      "id": 4844,
      "drug_code": 2684,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250433,
          "ingredient": {
            "id": 148,
            "ingredient_code": 2161,
            "en_name": "DINOPROSTONE",
            "fr_name": "Dinoprostone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00400688",
      "brand_name": "PROSTIN E2 TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50916",
      "number_of_ais": "1",
      "ai_group_no": "0111999004"
    },
    "created_date": "2024-12-19T18:21:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00400688",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G02AD",
    "atc_description": "UTEROTONICS",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2025-10-09T15:58:52-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PROSTIN E2 TABLETS",
    "en_drug_common_name": "PROSTIN E2 TABLETS",
    "fr_drug_brand_name": "PROSTIN E2 TABLETS",
    "fr_drug_common_name": "PROSTIN E2 TABLETS",
    "en_ingredients": "DINOPROSTONE",
    "fr_ingredients": "Dinoprostone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10'S TABLETS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246056,
    "drug": {
      "current_status": "MARKETED",
      "id": 96964,
      "drug_code": 78291,
      "updated_date": "2020-04-03T06:51:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256084,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256083,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297574",
      "brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
      "brand_name_fr": "APO-PERINDOPRIL-INDAPAMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401001"
    },
    "created_date": "2024-12-19T18:30:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297574",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2025-01-17T00:00:00-05:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-17T21:41:07-05:00",
    "status": "resolved",
    "en_comments": "30 BLS available",
    "fr_comments": "30 bls disponible",
    "en_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "en_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "fr_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "fr_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE\r\nPERINDOPRIL ERBUMINE",
    "fr_ingredients": "Indapamide\r\nPérindopril erbumine",
    "drug_strength": "1.25MG\r\n4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246059,
    "drug": {
      "current_status": "MARKETED",
      "id": 11512,
      "drug_code": 68271,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254282,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244304",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2024-12-19T18:31:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244304",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T18:15:01-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246062,
    "drug": {
      "current_status": "MARKETED",
      "id": 15998,
      "drug_code": 76783,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255720,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282178",
      "brand_name": "APO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332005"
    },
    "created_date": "2024-12-19T18:33:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282178",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-02-21T00:00:00-05:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-21T21:35:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "APO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone (Tartrate de rispéridone)",
    "drug_strength": "4.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246067,
    "drug": {
      "current_status": "MARKETED",
      "id": 61794,
      "drug_code": 96789,
      "updated_date": "2025-05-15T02:36:29-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8263309,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02477130",
      "brand_name": "APO-ACYCLOVIR OINTMENT",
      "brand_name_fr": "APO-ACYCLOVIR ONGUENT",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2024-12-19T18:34:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02477130",
    "company_name": "APOTEX INC",
    "atc_number": "D06BB",
    "atc_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
    "estimated_end_date": "2025-08-01T00:00:00-04:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR OINTMENT",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR OINTMENT",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246071,
    "drug": {
      "current_status": "MARKETED",
      "id": 4700,
      "drug_code": 2467,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250415,
          "ingredient": {
            "id": 1356,
            "ingredient_code": 10135,
            "en_name": "CHLORTHALIDONE",
            "fr_name": "Chlorthalidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00360279",
      "brand_name": "APO-CHLORTHALIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49739",
      "number_of_ais": "1",
      "ai_group_no": "0101804002"
    },
    "created_date": "2024-12-19T18:37:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00360279",
    "company_name": "APOTEX INC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "estimated_end_date": "2025-09-19T00:00:00-04:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-22T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CHLORTHALIDONE",
    "en_drug_common_name": "CHLORTHALIDONE",
    "fr_drug_brand_name": "APO-CHLORTHALIDONE",
    "fr_drug_common_name": "CHLORTHALIDONE",
    "en_ingredients": "CHLORTHALIDONE",
    "fr_ingredients": "Chlorthalidone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246092,
    "drug": {
      "current_status": "MARKETED",
      "id": 7720,
      "drug_code": 5072,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250704,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342092",
      "brand_name": "TEVA-CEPHALEXIN 250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59603",
      "number_of_ais": "1",
      "ai_group_no": "0105911002"
    },
    "created_date": "2024-12-19T18:49:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342092",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2025-02-20T00:00:00-05:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-06T18:22:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 250",
    "en_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "150ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246095,
    "drug": {
      "current_status": "MARKETED",
      "id": 7974,
      "drug_code": 5183,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250712,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00589861",
      "brand_name": "TEVA-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59858",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2024-12-19T18:50:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00589861",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-28T16:36:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN",
    "en_drug_common_name": "NAPROXEN 500MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN 500MG TAB",
    "fr_drug_common_name": "NAPROXEN 500MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246098,
    "drug": {
      "current_status": "MARKETED",
      "id": 1810,
      "drug_code": 13888,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251827,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00805009",
      "brand_name": "TEVA-TOPISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75364",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2024-12-19T18:51:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00805009",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2025-03-31T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-13T20:23:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPISONE",
    "en_drug_common_name": "TOPISONE 0.05% OINTMENT",
    "fr_drug_brand_name": "TEVA-TOPISONE 0.05% OINTMENT",
    "fr_drug_common_name": "TOPISONE 0.05% OINTMENT",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone (Dipropionate de bétaméthasone)",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246101,
    "drug": {
      "current_status": "MARKETED",
      "id": 32168,
      "drug_code": 9887,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251237,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00842656",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "UNCOATED",
      "pediatric_flag": false,
      "accession_number": "69243",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2024-12-19T18:53:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00842656",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-28T16:35:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 100MG UNCOAT TABS",
    "fr_drug_brand_name": "TEVA-METOPROLOL 100MG UNCOAT TABS",
    "fr_drug_common_name": "METOPROLOL 100MG UNCOAT TABS",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246104,
    "drug": {
      "current_status": "MARKETED",
      "id": 13092,
      "drug_code": 72459,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254769,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248130",
      "brand_name": "TEVA-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2024-12-19T18:56:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2025-03-31T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-27T19:53:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MOMETASONE",
    "en_drug_common_name": "MOMETASONE 0.1% OINTMENT",
    "fr_drug_brand_name": "TEVA-MOMETASONE 0.1% OINTMENT",
    "fr_drug_common_name": "MOMETASONE 0.1% OINTMENT",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246107,
    "drug": {
      "current_status": "MARKETED",
      "id": 19116,
      "drug_code": 80371,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256697,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318202",
      "brand_name": "TEVA-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2024-12-19T18:58:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318202",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-03-10T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-13T20:27:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM 20MG TABLETS",
    "fr_drug_brand_name": "TEVA-ESCITALOPRAM 20MG TABLETS",
    "fr_drug_common_name": "ESCITALOPRAM 20MG TABLETS",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram (Oxalate d'escitalopram)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246115,
    "drug": {
      "current_status": "MARKETED",
      "id": 27028,
      "drug_code": 89272,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259731,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408023",
      "brand_name": "FENTORA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302018"
    },
    "created_date": "2024-12-19T19:01:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408023",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-02-07T00:00:00-05:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-10T14:02:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FENTORA",
    "en_drug_common_name": "FENTORA 400MCG BUCCAL TAB",
    "fr_drug_brand_name": "FENTORA 400MCG BUCCAL TAB",
    "fr_drug_common_name": "FENTORA 400MCG BUCCAL TAB",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl (Citrate de fentanyl)",
    "drug_strength": "400MCG",
    "drug_dosage_form": "TABLET (EFFERVESCENT)",
    "drug_dosage_form_fr": "Comprimé (effervescent)",
    "drug_route": "SUBLINGUAL\r\nBUCCAL\r\nSUBLINGUAL\r\nBUCCAL",
    "drug_route_fr": "Sublinguale\r\nBuccale\r\nSublinguale\r\nBuccale",
    "drug_package_quantity": "PP28",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246118,
    "drug": {
      "current_status": "MARKETED",
      "id": 27442,
      "drug_code": 89676,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259928,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412195",
      "brand_name": "TEVA-TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202002"
    },
    "created_date": "2024-12-19T19:02:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412195",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2026-03-31T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-30T16:39:51-04:00",
    "status": "active_confirmed",
    "en_comments": "Item is on Suspended Supply",
    "en_drug_brand_name": "TEVA-TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE 2MG ER CAPSULES",
    "fr_drug_brand_name": "TEVA-TOLTERODINE 2MG ER CAPSULES",
    "fr_drug_common_name": "TOLTERODINE 2MG ER CAPSULES",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "2MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246144,
    "drug": {
      "current_status": "MARKETED",
      "id": 2988,
      "drug_code": 1736,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250301,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037788",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43658",
      "number_of_ais": "1",
      "ai_group_no": "0100053005"
    },
    "created_date": "2024-12-20T03:31:20-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00037788",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "discontinuation_date": "2025-02-06T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Expiry 31-DEC-2024",
    "fr_supply_disruption_mitigation": "Last lot expires 31-DEC-2024",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-02-20T05:22:56-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "fr_drug_common_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246147,
    "drug": {
      "current_status": "MARKETED",
      "id": 3018,
      "drug_code": 1747,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250312,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250311,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00038946",
      "brand_name": "5% DEXTROSE AND 0.9% SODIUM CHLORIDE",
      "brand_name_fr": "5% DEXTROSE ET 0,9% DE CHLORURE DE SODIUM",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43680",
      "number_of_ais": "2",
      "ai_group_no": "0200203001"
    },
    "created_date": "2024-12-20T03:38:47-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00038946",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2024-10-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot expiration date: 31-OCT-2024",
    "fr_supply_disruption_mitigation": "Last lot expiration date: 31-OCT-2024",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-12-20T03:40:00-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "5% DEXTROSE AND 0.9% SODIUM CHLORIDE",
    "en_drug_common_name": "Dextrose and Sodium Chloride Injection USP",
    "fr_drug_brand_name": "5% Dextrose et 0,9% de chlorure de sodium",
    "fr_drug_common_name": "Dextrose et chlorure de sodium injectables USP",
    "en_ingredients": "SODIUM CHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorure de sodium\r\nDextrose",
    "drug_strength": "9MG\r\n50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246198,
    "drug": {
      "current_status": "MARKETED",
      "id": 102099,
      "drug_code": 100698,
      "updated_date": "2021-08-09T05:14:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266398,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02517604",
      "brand_name": "PMS-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282001"
    },
    "created_date": "2024-12-20T15:34:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517604",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-04T13:53:06-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PMS-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "pms-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246205,
    "drug": {
      "current_status": "MARKETED",
      "id": 102100,
      "drug_code": 100699,
      "updated_date": "2021-08-09T05:14:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266399,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02517612",
      "brand_name": "PMS-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282002"
    },
    "created_date": "2024-12-20T15:37:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517612",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-04T13:53:36-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PMS-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "pms-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246210,
    "drug": {
      "current_status": "MARKETED",
      "id": 102101,
      "drug_code": 100700,
      "updated_date": "2021-08-09T05:14:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266400,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02517620",
      "brand_name": "PMS-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282003"
    },
    "created_date": "2024-12-20T15:39:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517620",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-04T13:54:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PMS-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "pms-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246213,
    "drug": {
      "current_status": "MARKETED",
      "id": 100959,
      "drug_code": 99407,
      "updated_date": "2020-10-02T23:55:46-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265571,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02504677",
      "brand_name": "PMS-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2024-12-20T15:42:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02504677",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L04AH",
    "estimated_end_date": "2025-01-24T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-27T14:19:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-EVEROLIMUS",
    "en_drug_common_name": "EVEROLIMUS",
    "fr_drug_brand_name": "pms-EVEROLIMUS",
    "fr_drug_common_name": "EVEROLIMUS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246216,
    "drug": {
      "current_status": "MARKETED",
      "id": 100960,
      "drug_code": 99408,
      "updated_date": "2020-10-02T23:55:46-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265572,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02504685",
      "brand_name": "PMS-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682001"
    },
    "created_date": "2024-12-20T15:44:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02504685",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L04AH",
    "estimated_end_date": "2025-01-24T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-27T14:19:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-EVEROLIMUS",
    "en_drug_common_name": "EVEROLIMUS",
    "fr_drug_brand_name": "pms-EVEROLIMUS",
    "fr_drug_common_name": "EVEROLIMUS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246219,
    "drug": {
      "current_status": "MARKETED",
      "id": 9524,
      "drug_code": 63098,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253702,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "21",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02239627",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643002"
    },
    "created_date": "2024-12-20T15:46:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239627",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2025-01-15T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-09T20:34:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRATROPIUM",
    "fr_drug_brand_name": "pms-IPRATROPIUM NASAL SPR",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "21MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246222,
    "drug": {
      "current_status": "MARKETED",
      "id": 28570,
      "drug_code": 90687,
      "updated_date": "2025-12-03T00:32:31-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260366,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.3",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02422166",
      "brand_name": "METHOTREXATE INJECTION, BP",
      "brand_name_fr": "",
      "descriptor": "(25 MG/ML). 0.3 ML SINGLE USE PREFILLED SYRINGE.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2024-12-20T15:49:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422166",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2025-01-30T00:00:00-05:00",
    "actual_start_date": "2024-12-19T00:00:00-05:00",
    "actual_end_date": "2025-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-05T19:35:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION, BP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE 7.5mg",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate (Méthotrexate sodique)",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL\r\nINTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle\r\nIntraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle",
    "drug_package_quantity": "0.3mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246225,
    "drug": {
      "current_status": "MARKETED",
      "id": 13188,
      "drug_code": 72643,
      "updated_date": "2025-12-03T00:30:55-05:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254793,
          "ingredient": {
            "id": 3090,
            "ingredient_code": 12297,
            "en_name": "GADOBENATE DIMEGLUMINE",
            "fr_name": "Diméglumine de gadobénate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "529",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248302",
      "brand_name": "MULTIHANCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149628001"
    },
    "created_date": "2024-12-20T15:51:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248302",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "estimated_end_date": "2025-02-14T00:00:00-05:00",
    "actual_start_date": "2024-12-17T00:00:00-05:00",
    "actual_end_date": "2025-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-17T13:36:09-04:00",
    "status": "resolved",
    "en_comments": "The manufacturing and release of the product at the approved manufacturing site are suspended until issue is identified and resolved.",
    "fr_comments": "La fabrication et la relache des lots du produit au site de fabrication approuvé sont suspendues jusqu'à ce que le problème soit identifié et résolu",
    "en_drug_brand_name": "MULTIHANCE",
    "en_drug_common_name": "Gadobenate Dimeglumine injection",
    "fr_drug_brand_name": "MultiHance",
    "fr_drug_common_name": "Gadobenate Dimeglumine injection",
    "en_ingredients": "GADOBENATE DIMEGLUMINE",
    "fr_ingredients": "Diméglumine de gadobénate",
    "drug_strength": "529MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ml, 10ml,15ml, 20ml, 50ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246254,
    "drug": {
      "current_status": "MARKETED",
      "id": 19584,
      "drug_code": 80958,
      "updated_date": "2025-05-15T02:32:21-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256831,
          "ingredient": {
            "id": 1410,
            "ingredient_code": 20259,
            "en_name": "EPIRUBICIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'épirubicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02324091",
      "brand_name": "EPIRUBICIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116901002"
    },
    "created_date": "2024-12-20T18:09:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324091",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "actual_start_date": "2025-01-17T00:00:00-05:00",
    "actual_end_date": "2025-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-18T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Shortage averted",
    "en_drug_brand_name": "EPIRUBICIN FOR INJECTION",
    "en_drug_common_name": "EPIRUBICIN FOR INJECTION",
    "fr_drug_brand_name": "EPIRUBICIN FOR INJECTION",
    "fr_drug_common_name": "EPIRUBICIN FOR INJECTION",
    "en_ingredients": "EPIRUBICIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'épirubicine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5, 25, & 100ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246267,
    "drug": {
      "current_status": "MARKETED",
      "id": 4044,
      "drug_code": 19756,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252566,
          "ingredient": {
            "id": 1604,
            "ingredient_code": 5895,
            "en_name": "VINCRISTINE SULFATE",
            "fr_name": "Sulfate de vincristine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02143305",
      "brand_name": "VINCRISTINE SULFATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82052",
      "number_of_ais": "1",
      "ai_group_no": "0107646001"
    },
    "created_date": "2024-12-20T18:17:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02143305",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2025-10-31T00:00:00-04:00",
    "actual_start_date": "2025-04-09T00:00:00-04:00",
    "actual_end_date": "2025-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-23T20:27:47-04:00",
    "status": "resolved",
    "en_comments": "Equipment issue at MFG.",
    "en_drug_brand_name": "VINCRISTINE SULFATE INJECTION",
    "en_drug_common_name": "VINCRISTINE SULFATE INJECTION",
    "fr_drug_brand_name": "VINCRISTINE SULFATE INJECTION",
    "fr_drug_common_name": "VINCRISTINE SULFATE INJECTION",
    "en_ingredients": "VINCRISTINE SULFATE",
    "fr_ingredients": "Sulfate de vincristine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 246290,
    "drug": {
      "current_status": "MARKETED",
      "id": 50270,
      "drug_code": 94350,
      "updated_date": "2025-12-03T00:33:09-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262046,
          "ingredient": {
            "id": 6503,
            "ingredient_code": 22757,
            "en_name": "BEPOTASTINE BESILATE",
            "fr_name": "Bésilate de bépotastine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02456532",
      "brand_name": "BEPREVE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158330001"
    },
    "created_date": "2024-12-20T21:12:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456532",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01",
    "atc_description": "L3 not assigned",
    "anticipated_start_date": "2024-12-20T00:00:00-05:00",
    "estimated_end_date": "2025-01-15T00:00:00-05:00",
    "actual_end_date": "2025-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-01-09T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Delay of distribution of the drug",
    "fr_comments": "Delay of distribution of the drug",
    "en_drug_brand_name": "BEPREVE",
    "en_drug_common_name": "B&LCN BEPREVE 1.5% SOLN 5ML",
    "fr_drug_brand_name": "Bausch & Lomb",
    "fr_drug_common_name": "B&LCN BEPREVE 1.5% SOLN 5ML",
    "en_ingredients": "BEPOTASTINE BESILATE",
    "fr_ingredients": "Bésilate de bepotastine",
    "drug_strength": "1.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246306,
    "drug": {
      "current_status": "MARKETED",
      "id": 30686,
      "drug_code": 92742,
      "updated_date": "2025-05-15T02:34:54-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261279,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442914",
      "brand_name": "RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2024-12-23T12:52:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442914",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-28T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN ODT",
    "fr_drug_brand_name": "RIZATRIPTAN ODT",
    "fr_drug_common_name": "RIZATRIPTAN ODT",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan (Benzoate de rizatriptan)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246341,
    "drug": {
      "current_status": "MARKETED",
      "id": 102438,
      "drug_code": 101082,
      "updated_date": "2021-11-08T06:10:12-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266690,
          "ingredient": {
            "id": 3736,
            "ingredient_code": 20883,
            "en_name": "ABIRATERONE ACETATE",
            "fr_name": "Acétate d'abiratérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02521644",
      "brand_name": "SANDOZ ABIRATERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152948002"
    },
    "created_date": "2024-12-23T13:30:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02521644",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L02BX",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2025-02-14T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-18T02:56:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ABIRATERONE",
    "en_drug_common_name": "ABIRATERONE",
    "fr_drug_brand_name": "SANDOZ ABIRATERONE",
    "fr_drug_common_name": "ABIRATERONE",
    "en_ingredients": "ABIRATERONE ACETATE",
    "fr_ingredients": "Acétate d'abiratérone",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246345,
    "drug": {
      "current_status": "MARKETED",
      "id": 105063,
      "drug_code": 103497,
      "updated_date": "2024-07-09T04:40:30-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8268788,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02546264",
      "brand_name": "SANDOZ LISDEXAMFETAMINE CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536001"
    },
    "created_date": "2024-12-23T13:32:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02546264",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T01:24:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LISDEXAMFETAMINE CAPSULES",
    "en_drug_common_name": "LISDEXAMFETAMINE CAPSULES",
    "fr_drug_brand_name": "SANDOZ LISDEXAMFETAMINE CAPSULES",
    "fr_drug_common_name": "LISDEXAMFETAMINE CAPSULES",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100HGC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246349,
    "drug": {
      "current_status": "MARKETED",
      "id": 23796,
      "drug_code": 86463,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258576,
          "ingredient": {
            "id": 2158,
            "ingredient_code": 41,
            "en_name": "MEROPENEM",
            "fr_name": "Méropénem (Méropénem Trihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378787",
      "brand_name": "MEROPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128599001"
    },
    "created_date": "2024-12-23T13:35:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378787",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:42:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MEROPENEM FOR INJECTION",
    "en_drug_common_name": "MEROPENEM FOR INJECTION",
    "fr_drug_brand_name": "SANDOZ MEROPENEM FOR INJECTION",
    "fr_drug_common_name": "MEROPENEM FOR INJECTION",
    "en_ingredients": "MEROPENEM",
    "fr_ingredients": "Méropénem (Méropénem Trihydraté)",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10PSOIJ",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246353,
    "drug": {
      "current_status": "MARKETED",
      "id": 18662,
      "drug_code": 79937,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256534,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313855",
      "brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2024-12-23T13:41:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313855",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:43:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "en_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "fr_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "fr_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246356,
    "drug": {
      "current_status": "MARKETED",
      "id": 20192,
      "drug_code": 81627,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257164,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8257163,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02330547",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919007"
    },
    "created_date": "2024-12-23T13:44:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330547",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2025-01-31T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2025-02-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-04T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "fr_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "fr_drug_common_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_ingredients": "TAZOBACTAM\r\nPIPERACILLIN",
    "fr_ingredients": "Tazobactam (Tazobactam sodique)\r\nPipéracilline (Pipéracilline sodique)",
    "drug_strength": "1.5G\r\n12G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1PSOIJ",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246360,
    "drug": {
      "current_status": "MARKETED",
      "id": 23550,
      "drug_code": 86141,
      "updated_date": "2025-05-15T02:33:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258498,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375958",
      "brand_name": "SANDOZ TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2024-12-23T13:58:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375958",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-01-10T00:00:00-05:00",
    "actual_start_date": "2024-12-23T00:00:00-05:00",
    "actual_end_date": "2024-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-01-14T00:46:26-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SANDOZ TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "SANDOZ TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 TAB",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246406,
    "drug": {
      "current_status": "MARKETED",
      "id": 30352,
      "drug_code": 92402,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8261092,
          "ingredient": {
            "id": 2314,
            "ingredient_code": 11115,
            "en_name": "INSULIN LISPRO",
            "fr_name": "Insuline lispro"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439611",
      "brand_name": "HUMALOG 200 UNITS/ML KWIKPEN",
      "brand_name_fr": "",
      "descriptor": "PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131614002"
    },
    "created_date": "2024-12-23T20:35:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439611",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "anticipated_start_date": "2024-12-20T00:00:00-05:00",
    "estimated_end_date": "2025-01-15T00:00:00-05:00",
    "actual_start_date": "2024-12-20T00:00:00-05:00",
    "actual_end_date": "2025-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-01-16T06:00:12-05:00",
    "status": "resolved",
    "en_comments": "The estimated end date represents projected availability at the main Lilly warehouse.  For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_comments": "La date de fin estimée représente la disponibilité prévue à l’entrepôt principal de Lilly.  Pour toute question ou préoccupation, veuillez communiquer avec notre Centre de réponse à la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, à l’exclusion des jours fériés).",
    "en_drug_brand_name": "HUMALOG 200 UNITS/ML KWIKPEN",
    "en_drug_common_name": "INSULIN LISPRO",
    "fr_drug_brand_name": "HUMALOG® KwikPen® à 200 unités/mL",
    "fr_drug_common_name": "insuline lispro",
    "en_ingredients": "INSULIN LISPRO",
    "fr_ingredients": "Insuline lispro",
    "drug_strength": "200UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "Carton package containing 5 prefilled pens",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246441,
    "drug": {
      "current_status": "MARKETED",
      "id": 18448,
      "drug_code": 79707,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256457,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311518",
      "brand_name": "PRO-AAS - 80 (CROQUABLE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101169013"
    },
    "created_date": "2024-12-24T14:16:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311518",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2025-02-28T00:00:00-05:00",
    "actual_start_date": "2024-12-24T00:00:00-05:00",
    "actual_end_date": "2025-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-02-22T06:00:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-AAS - 80 (CROQUABLE)",
    "en_drug_common_name": "AAS 80 (CROQUABLE)",
    "fr_drug_brand_name": "PRO AAS 80 (CROQUABLE)",
    "fr_drug_common_name": "AAS 80 (CROQUABLE)",
    "en_ingredients": "ACETYLSALICYLIC ACID",
    "fr_ingredients": "Acide acétylsalicylique",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246460,
    "drug": {
      "current_status": "MARKETED",
      "id": 5546,
      "drug_code": 36946,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252869,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213206",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "ELTROXIN",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4372",
      "number_of_ais": "1",
      "ai_group_no": "0107794005"
    },
    "created_date": "2024-12-24T15:21:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213206",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2025-05-31T00:00:00-04:00",
    "actual_start_date": "2024-12-18T00:00:00-05:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-08T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "GR10011CA1\tELTROXIN 100MCG TAB BOT 500 CA ASP",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "levothyroxine sodium",
    "fr_drug_brand_name": "Eltroxin®",
    "fr_drug_common_name": "levothyroxine sodium",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246465,
    "drug": {
      "current_status": "MARKETED",
      "id": 4918,
      "drug_code": 2789,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250446,
          "ingredient": {
            "id": 812,
            "ingredient_code": 16112,
            "en_name": "CHLORAMPHENICOL",
            "fr_name": "Chloramphénicol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00312363",
      "brand_name": "CHLOROMYCETIN SUCCINATE INJECTION",
      "brand_name_fr": "CHLOROMYCETIN SUCCINATE INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51334",
      "number_of_ais": "1",
      "ai_group_no": "0151341001"
    },
    "created_date": "2024-12-24T15:58:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00312363",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "J01BA",
    "atc_description": "AMPHENICOLS",
    "anticipated_start_date": "2025-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-02T05:00:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "CHLOROMYCETIN SUCCINATE INJECTION",
    "en_drug_common_name": "Chloromycetin",
    "fr_drug_brand_name": "Chloromycetin",
    "fr_drug_common_name": "Chloromycetin",
    "en_ingredients": "CHLORAMPHENICOL",
    "fr_ingredients": "Chloramphénicol",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Vial",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 246470,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2634,
      "drug_code": 16274,
      "updated_date": "2025-12-03T01:07:41-05:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8296751,
          "ingredient": {
            "id": 1072,
            "ingredient_code": 7330,
            "en_name": "GONADORELIN ACETATE",
            "fr_name": "Acétate de gonadoréline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02046210",
      "brand_name": "LUTREPULSE PWS 0.8MG/VIAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78155",
      "number_of_ais": "1",
      "ai_group_no": "0121867002"
    },
    "created_date": "2024-12-24T17:56:12-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02046210",
    "company_name": "FERRING INC",
    "atc_number": "H01CA",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "discontinuation_date": "2024-11-26T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All global remaining supply has expired.",
    "en_discontinuation_comments": "Lutrapulse 0.8mg is no longer available worldwide beyond June 30, 2024 due to expiry dating of existing supply. No new product will be manufactured or is available due to manufacturing line decommissioning.",
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2024-12-24T17:56:49-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "LUTREPULSE PWS 0.8MG/VIAL",
    "en_drug_common_name": "Gonadorelin Acetate",
    "fr_drug_brand_name": "Lutrepulse",
    "fr_drug_common_name": "Gonadorelin Acetate",
    "en_ingredients": "GONADORELIN ACETATE",
    "fr_ingredients": "Acétate de gonadoréline",
    "drug_strength": "0.8MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10mL vial",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  }
]